KR101600434B1 - New organic electroluminescent compounds and organic electroluminescent device comprising the same - Google Patents

New organic electroluminescent compounds and organic electroluminescent device comprising the same Download PDF

Info

Publication number
KR101600434B1
KR101600434B1 KR1020150076325A KR20150076325A KR101600434B1 KR 101600434 B1 KR101600434 B1 KR 101600434B1 KR 1020150076325 A KR1020150076325 A KR 1020150076325A KR 20150076325 A KR20150076325 A KR 20150076325A KR 101600434 B1 KR101600434 B1 KR 101600434B1
Authority
KR
South Korea
Prior art keywords
compound
synthesis
cdcl
fab
nmr
Prior art date
Application number
KR1020150076325A
Other languages
Korean (ko)
Other versions
KR20150066509A (en
Inventor
안도환
박재교
전아람
이대균
한근희
현승학
안중복
김복영
박노길
Original Assignee
주식회사 엠비케이
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 엠비케이 filed Critical 주식회사 엠비케이
Publication of KR20150066509A publication Critical patent/KR20150066509A/en
Application granted granted Critical
Publication of KR101600434B1 publication Critical patent/KR101600434B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • H01L51/006
    • H01L51/0071
    • H01L51/5016
    • H01L51/504
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/11OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/11OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
    • H10K50/125OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers specially adapted for multicolour light emission, e.g. for emitting white light
    • H10K50/13OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers specially adapted for multicolour light emission, e.g. for emitting white light comprising stacked EL layers within one EL unit
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/631Amine compounds having at least two aryl rest on at least one amine-nitrogen atom, e.g. triphenylamine
    • H10K85/633Amine compounds having at least two aryl rest on at least one amine-nitrogen atom, e.g. triphenylamine comprising polycyclic condensed aromatic hydrocarbons as substituents on the nitrogen atom
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1029Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1059Heterocyclic compounds characterised by ligands containing three nitrogen atoms as heteroatoms

Abstract

본 발명은 하기 화학식 1로 표시되는 유기발광화합물 및 이를 포함하는 유기전기발광소자를 제공한다:
[ 화학식1 ]

Figure 112015052111785-pat00165

상기 유기발광화합물은 인광 녹색 호스트 물질로서 유기전기발광소자에 적용될 수 있으며, 이 경우 유기전기발광소자의 발광효율 및 소자 수명을 향상시킬 수 있다.
The present invention provides an organic electroluminescent compound represented by the following Formula 1 and an organic electroluminescent device comprising the same:
[ Chemical Formula 1 ]
Figure 112015052111785-pat00165

The organic luminescent compound may be applied to an organic electroluminescent device as a phosphorescent green host material. In this case, the luminescent efficiency and lifetime of the organic electroluminescent device can be improved.

Description

신규한 유기발광화합물 및 이를 포함하는 유기전기발광소자{NEW ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME}BACKGROUND OF THE INVENTION 1. Field of the Invention [0001] The present invention relates to a novel organic electroluminescent compound and an organic electroluminescent device including the same.

본 발명은 신규한 유기발광화합물 및 이를 포함하는 유기전기발광소자에 관한 것으로, 보다 구체적으로는 인광 녹색 호스트 물질로서 사용되는 신규한 유기발광화합물 및 이를 채용하고 있는 유기 발광 소자에 관한 것이다.
The present invention relates to a novel organic light emitting compound and an organic electroluminescent device including the same, and more particularly, to a novel organic light emitting compound used as a phosphorescent green host material and an organic light emitting device employing the same.

OLED에서 발광 효율을 결정하는 가장 중요한 요인은 발광 재료이다. 발광 재료로는 현재까지 형광 재료가 널리 사용되고 있으나, 전기발광의 메커니즘 상 인광 재료의 개발은 이론적으로 4배까지 발광 효율을 개선시킬 수 있는 가장 좋은 방법 중 하나이다. 현재까지 이리듐(III)착물 계열이 인광 발광 재료로 널리 알려져 있으며, 각 RGB 별로는 (acac)Ir(btp)2, Ir(ppy)3 및 Firpic 등의 재료가 알려져 있다. 특히, 최근 일본, 구미에서 많은 인광 재료들이 연구되고 있다.The most important factor determining the luminous efficiency in an OLED is a light emitting material. Fluorescent materials are widely used as luminescent materials to date, but the development of a phosphorescent material on the mechanism of electroluminescence is one of the best ways to improve the luminous efficiency up to 4 times theoretically. Until now, iridium (III) complexes have been widely known as phosphorescent materials. Materials such as (acac) Ir (btp) 2, Ir (ppy) 3 and Firpic are known for each RGB. Recently, many phosphorescent materials have been studied in Japan and Europe.

인광 발광체의 호스트 재료로는 현재까지 CBP가 가장 널리 알려져 있으며, BCP, BAlq 등의 정공차단층을 적용한 고효율의 OLED가 공지되어 있으며, 일본의 파이오니어 등에서는 BAlq유도체를 호스트로 이용한 고성능의 OLED를 공지한 바 있다.CBP is the most widely known host material for a phosphorescent light emitting material, and a high efficiency OLED using a hole blocking layer such as BCP and BAlq is known. In Pioneer Japan, a high performance OLED using a BAlq derivative as a host is known There is one.

그러나 기존의 재료들은 발광 특성 측면에서는 유리한 면이 있으나, 유리전이온도가 낮고 열적 안정성이 매우 좋지 않아서, 진공 하에서 고온 증착 공정을 거칠 때, 물질이 변하는 등 단점을 갖고 있다. OLED에서 전력효율= (π/전압) ㅧ 전류효율 이므로, 전력효율은 전압에 반비례하는데, OLED의 소비 전력이 낮으려면 전력 효율이 높아야한다. 실제 인광 발광 재료를 사용한 OLED는 형광 발광 재료를 사용한 OLED에 비해 전류 효율(cd/A)이 상당히 높으나, 인광 발광 재료의 호스트로 BAlq나 CBP 등 종래의 재료를 사용할 경우, 형광재료를 사용한 OLED에 비해 구동 전압이 높아서 전력 효율(lm/w)면에서 큰 이점이 없다. 또한, OLED 소자에서의 수명 측면에서도 결코 만족할만한 수준이 되질 못하여 더욱 안정되고, 더욱 성능이 뛰어난 호스트 재료의 개발이 요구되고 있다.
However, existing materials have advantages in terms of luminescent properties, but they have disadvantages such as low glass transition temperature and very poor thermal stability, which can cause material changes when subjected to a high temperature deposition process under vacuum. Because OLEDs have power efficiency = (π / voltage) ㅧ current efficiency, the power efficiency is inversely proportional to the voltage. OLEDs using real phosphorescent materials have significantly higher current efficiency (cd / A) than OLEDs using fluorescent materials. However, when conventional materials such as BAlq and CBP are used as hosts for phosphorescent materials, OLEDs using fluorescent materials (Lm / w) since the driving voltage is high. In addition, since the lifetime of the OLED device is never satisfactory, development of a more stable and more excellent host material is required.

본 발명은 인광 녹색 호스트 물질로서 유기 발광 소자에 적용할 수 있고, 유기 발광 소자에 적용할 경우 구동전압을 낮출 수 있으며, 발광효율, 휘도, 열적 안정성 및 소자 수명을 향상시킬 수 있는 유기발광화합물을 제공하는 것을 목적으로 한다.The present invention can be applied to an organic light emitting device as a phosphorescent green host material, and to an organic luminescent compound which can lower a driving voltage when applied to an organic luminescent device and improve luminous efficiency, brightness, thermal stability, The purpose is to provide.

또한, 본 발명은 상기 화합물을 이용한 유기 발광 소자를 제공하는 것을 목적으로 한다.
Another object of the present invention is to provide an organic light emitting device using the above compound.

본 발명은 하기 화학식 1로 표시되는 유기발광화합물을 제공한다:The present invention provides an organic electroluminescent compound represented by the following formula (1): < EMI ID =

[[ 화학식1Formula 1 ]]

Figure 112015052111785-pat00001
Figure 112015052111785-pat00001

상기 식에서,In this formula,

X는

Figure 112015052111785-pat00002
,
Figure 112015052111785-pat00003
,
Figure 112015052111785-pat00004
,
Figure 112015052111785-pat00005
,
Figure 112015052111785-pat00006
,
Figure 112015052111785-pat00007
,
Figure 112015052111785-pat00008
,
Figure 112015052111785-pat00009
,
Figure 112015052111785-pat00010
,
Figure 112015052111785-pat00011
,
Figure 112015052111785-pat00012
,
Figure 112015052111785-pat00013
,
Figure 112015052111785-pat00014
,
Figure 112015052111785-pat00015
,
Figure 112015052111785-pat00016
,
Figure 112015052111785-pat00017
,
Figure 112015052111785-pat00018
,
Figure 112015052111785-pat00019
,
Figure 112015052111785-pat00020
,
Figure 112015052111785-pat00021
,
Figure 112015052111785-pat00022
,
Figure 112015052111785-pat00023
,
Figure 112015052111785-pat00024
,
Figure 112015052111785-pat00025
,
Figure 112015052111785-pat00026
,
Figure 112015052111785-pat00027
,
Figure 112015052111785-pat00028
,
Figure 112015052111785-pat00029
또는
Figure 112015052111785-pat00030
이며, 상기에서 W는 질소원자, 산소원자, 황원자 또는 Si(C1~C5의 알킬)2이며, R1은 각각 독립적으로 페닐, 피롤, 피라졸, 이미다졸, 트리아졸, 피리디닐, 피리미디닐, 피라지닐, 피리다지닐, 트리아지닐 또는 나프틸기이며, W가 산소원자, 황원자 또는 Si(C1~C5의 알킬)2인 경우에 R1은 부존재하며, A 및 B는 각각 독립적으로 탄소원자 또는 질소원자이며;X is
Figure 112015052111785-pat00002
,
Figure 112015052111785-pat00003
,
Figure 112015052111785-pat00004
,
Figure 112015052111785-pat00005
,
Figure 112015052111785-pat00006
,
Figure 112015052111785-pat00007
,
Figure 112015052111785-pat00008
,
Figure 112015052111785-pat00009
,
Figure 112015052111785-pat00010
,
Figure 112015052111785-pat00011
,
Figure 112015052111785-pat00012
,
Figure 112015052111785-pat00013
,
Figure 112015052111785-pat00014
,
Figure 112015052111785-pat00015
,
Figure 112015052111785-pat00016
,
Figure 112015052111785-pat00017
,
Figure 112015052111785-pat00018
,
Figure 112015052111785-pat00019
,
Figure 112015052111785-pat00020
,
Figure 112015052111785-pat00021
,
Figure 112015052111785-pat00022
,
Figure 112015052111785-pat00023
,
Figure 112015052111785-pat00024
,
Figure 112015052111785-pat00025
,
Figure 112015052111785-pat00026
,
Figure 112015052111785-pat00027
,
Figure 112015052111785-pat00028
,
Figure 112015052111785-pat00029
or
Figure 112015052111785-pat00030
Wherein W is a nitrogen atom, an oxygen atom, a sulfur atom or Si (C1 to C5 alkyl) 2 , and each R1 is independently phenyl, pyrrole, pyrazole, imidazole, triazole, pyridinyl, pyrimidinyl, R 1 is absent when A is an oxygen atom, sulfur atom or Si (C1 to C5 alkyl) 2 , A and B are each independently a carbon atom or a nitrogen atom ;

Y는 질소 또는 탄소원자이며, Y 중 적어도 하나는 질소원자이며;Y is a nitrogen or carbon atom, and at least one of Y is a nitrogen atom;

Z는 단순결합이거나, 부존재이며;Z is a simple bond or absent;

R2 및 R3는 각각 독립적으로 수소원자, C1~C10의 직쇄 알킬, C3~C10의 분지쇄 알킬, C1~C10의 알콕시, 할로겐, 니트릴, CF3또는 Si(CH3)3이거나,R2 and R3 are each independently a hydrogen atom, a C1 ~ C10 straight chain alkyl, C3 ~ C10 branched alkyl, alkoxy, halogen, nitrile of C1 ~ C10, CF 3 or Si (CH 3) 3, or,

중수소원자, C1~C10의 직쇄 알킬, C3~C10의 분지쇄 알킬, C1~C10의 알콕시, 할로겐, 니트릴, CF3,Si(CH3)3,페닐, 바이페닐, 나프틸, 페난트레닐, 플루오레닐, 피롤, 피라졸, 이미다졸, 트리아졸, 옥사졸, 옥사디아졸, 티오페닐, 티아졸, 티아디아졸, 피라지닐, 피리다지닐 피리디닐, 피리미디닐 및 트리아지닐기로 이루어진 군으로부터 선택되는 하나 이상의 치환기로 치환 또는 비치환된 탄소수 6~30의 아릴기 또는 탄소수 5~60의 헤테로아릴기이다.A heavy hydrogen atom, C1 ~ C10 straight chain alkyl, C3 ~ C10 branched alkyl, alkoxy of C1 ~ C10, halogen, nitrile, CF 3, Si (CH 3 ) 3, phenyl, biphenyl, naphthyl, phenanthrenyl, A group consisting of a fluorenyl, a pyrrole, a pyrazole, an imidazole, a triazole, an oxazole, an oxadiazole, a thiophenyl, a thiazole, a thiadiazole, a pyrazinyl, a pyridazinylpyridinyl, a pyrimidinyl and a triazinyl group A substituted or unsubstituted aryl group having 6 to 30 carbon atoms or a heteroaryl group having 5 to 60 carbon atoms.

또한, 본 발명은, Further, according to the present invention,

음극과 양극 사이에 적어도 발광층을 포함하는 일층 또는 복수층으로 이루어지는 유기 박막층이 협지되어 있는 유기전기발광소자에 있어서, An organic electroluminescent device in which an organic thin film layer composed of one layer or a plurality of layers including at least a light emitting layer is sandwiched between a cathode and an anode,

상기 유기 박막층 중 적어도 1층이 본 발명의 유기발광화합물을 1종 단독으로 또는 2종 이상의 조합으로 함유하는 것을 특징으로 하는 유기전기발광소자를 제공한다.
At least one of the organic thin film layers contains the organic electroluminescent compound of the present invention singly or in combination of two or more.

본 발명에 따른 유기발광화합물은 인광 녹색 호스트 물질로서 유기 발광 소자에 적용할 수 있으며, 유기 발광 소자에 적용할 경우 구동전압을 낮추며, 발광효율, 휘도, 열적 안정성 및 소자 수명을 향상시킨다. The organic electroluminescent compound according to the present invention can be applied to an organic electroluminescent device as a phosphorescent green host material. When applied to an organic electroluminescent device, the electroluminescent compound lowers a driving voltage and improves luminous efficiency, brightness, thermal stability, and device lifetime.

또한, 본 발명의 유기발광화합물을 사용하여 제조되는 유기전기발광 소자는 고효율 및 장수명 특성을 갖는다.
In addition, the organic electroluminescent device manufactured using the organic electroluminescent compound of the present invention has high efficiency and long life.

본 발명은 하기 화학식 1로 표시되는 유기발광화합물에 관한 것이다:The present invention relates to organic electroluminescent compounds represented by the following general formula (1)

[[ 화학식1Formula 1 ]]

Figure 112015052111785-pat00031
Figure 112015052111785-pat00031

상기 식에서,In this formula,

X는

Figure 112015052111785-pat00032
,
Figure 112015052111785-pat00033
,
Figure 112015052111785-pat00034
,
Figure 112015052111785-pat00035
,
Figure 112015052111785-pat00036
,
Figure 112015052111785-pat00037
,
Figure 112015052111785-pat00038
,
Figure 112015052111785-pat00039
,
Figure 112015052111785-pat00040
,
Figure 112015052111785-pat00041
,
Figure 112015052111785-pat00042
,
Figure 112015052111785-pat00043
,
Figure 112015052111785-pat00044
,
Figure 112015052111785-pat00045
,
Figure 112015052111785-pat00046
,
Figure 112015052111785-pat00047
,
Figure 112015052111785-pat00048
,
Figure 112015052111785-pat00049
,
Figure 112015052111785-pat00050
,
Figure 112015052111785-pat00051
,
Figure 112015052111785-pat00052
,
Figure 112015052111785-pat00053
,
Figure 112015052111785-pat00054
,
Figure 112015052111785-pat00055
,
Figure 112015052111785-pat00056
,
Figure 112015052111785-pat00057
,
Figure 112015052111785-pat00058
,
Figure 112015052111785-pat00059
또는
Figure 112015052111785-pat00060
이며, 상기에서 W는 질소원자, 산소원자, 황원자 또는 Si(C1~C5의 알킬)2이며, R1은 각각 독립적으로 페닐, 피롤, 피라졸, 이미다졸, 트리아졸, 피리디닐, 피리미디닐, 피라지닐, 피리다지닐, 트리아지닐 또는 나프틸기이며, W가 산소원자, 황원자 또는 Si(C1~C5의 알킬)2인 경우에 R1은 부존재하며, A 및 B는 각각 독립적으로 탄소원자 또는 질소원자이며;X is
Figure 112015052111785-pat00032
,
Figure 112015052111785-pat00033
,
Figure 112015052111785-pat00034
,
Figure 112015052111785-pat00035
,
Figure 112015052111785-pat00036
,
Figure 112015052111785-pat00037
,
Figure 112015052111785-pat00038
,
Figure 112015052111785-pat00039
,
Figure 112015052111785-pat00040
,
Figure 112015052111785-pat00041
,
Figure 112015052111785-pat00042
,
Figure 112015052111785-pat00043
,
Figure 112015052111785-pat00044
,
Figure 112015052111785-pat00045
,
Figure 112015052111785-pat00046
,
Figure 112015052111785-pat00047
,
Figure 112015052111785-pat00048
,
Figure 112015052111785-pat00049
,
Figure 112015052111785-pat00050
,
Figure 112015052111785-pat00051
,
Figure 112015052111785-pat00052
,
Figure 112015052111785-pat00053
,
Figure 112015052111785-pat00054
,
Figure 112015052111785-pat00055
,
Figure 112015052111785-pat00056
,
Figure 112015052111785-pat00057
,
Figure 112015052111785-pat00058
,
Figure 112015052111785-pat00059
or
Figure 112015052111785-pat00060
Wherein W is a nitrogen atom, an oxygen atom, a sulfur atom or Si (C1 to C5 alkyl) 2 , and each R1 is independently phenyl, pyrrole, pyrazole, imidazole, triazole, pyridinyl, pyrimidinyl, R 1 is absent when A is an oxygen atom, sulfur atom or Si (C1 to C5 alkyl) 2 , A and B are each independently a carbon atom or a nitrogen atom ;

Y는 질소 또는 탄소원자이며, Y 중 적어도 하나는 질소원자이며;Y is a nitrogen or carbon atom, and at least one of Y is a nitrogen atom;

Z는 단순결합이거나, 부존재이며;Z is a simple bond or absent;

R2 및 R3는 각각 독립적으로 수소원자, C1~C10의 직쇄 알킬, C3~C10의 분지쇄 알킬, C1~C10의 알콕시, 할로겐, 니트릴, CF3또는 Si(CH3)3이거나,R2 and R3 are each independently a hydrogen atom, a C1 ~ C10 straight chain alkyl, C3 ~ C10 branched alkyl, alkoxy, halogen, nitrile of C1 ~ C10, CF 3 or Si (CH 3) 3, or,

중수소원자, C1~C10의 직쇄 알킬, C3~C10의 분지쇄 알킬, C1~C10의 알콕시, 할로겐, 니트릴, CF3,Si(CH3)3,페닐, 바이페닐, 나프틸, 페난트레닐, 플루오레닐, 피롤, 피라졸, 이미다졸, 트리아졸, 옥사졸, 옥사디아졸, 티오페닐, 티아졸, 티아디아졸, 피라지닐, 피리다지닐 피리디닐, 피리미디닐 및 트리아지닐기로 이루어진 군으로부터 선택되는 하나 이상의 치환기로 치환 또는 비치환된 탄소수 6~30의 아릴기 또는 탄소수 5~60의 헤테로아릴기이다.A heavy hydrogen atom, C1 ~ C10 straight chain alkyl, C3 ~ C10 branched alkyl, alkoxy of C1 ~ C10, halogen, nitrile, CF 3, Si (CH 3 ) 3, phenyl, biphenyl, naphthyl, phenanthrenyl, A group consisting of a fluorenyl, a pyrrole, a pyrazole, an imidazole, a triazole, an oxazole, an oxadiazole, a thiophenyl, a thiazole, a thiadiazole, a pyrazinyl, a pyridazinylpyridinyl, a pyrimidinyl and a triazinyl group A substituted or unsubstituted aryl group having 6 to 30 carbon atoms or a heteroaryl group having 5 to 60 carbon atoms.

바람직하게는, 상기 탄소수 6~30의 아릴 또는 탄소수 5~60의 헤테로아릴은 페닐, 나프틸, 바이페닐, 바이나프틸, 페난트레닐, 플루오레닐, 피롤, 피라졸, 이미다졸, 트리아졸, 옥사졸, 옥사디아졸, 티오페닐, 티아졸, 티아디아졸, 피리디닐, 피리미디닐, 피라지닐, 피리다지닐, 트리아지닐, 벤조티오페닐, 벤즈이미다졸, 벤조옥사졸, 벤즈티아졸, 카바졸, 퀴놀리닐, 이소퀴놀리닐, 인돌 또는 피레닐기일 수 있다.Preferably, the aryl of 6 to 30 carbon atoms or the heteroaryl of 5 to 60 carbon atoms is phenyl, naphthyl, biphenyl, binaphthyl, phenanthrenyl, fluorenyl, pyrrole, pyrazole, imidazole, triazole , Oxazole, oxadiazole, thiophenyl, thiazole, thiadiazole, pyridinyl, pyrimidinyl, pyrazinyl, pyridazinyl, triazinyl, benzothiophenyl, benzimidazole, benzoxazole, benzthiazole , Carbazole, quinolinyl, isoquinolinyl, indole or pyrenyl group.

상기에서 더욱 바람직하게는,More preferably,

X는

Figure 112015052111785-pat00061
,
Figure 112015052111785-pat00062
,
Figure 112015052111785-pat00063
,
Figure 112015052111785-pat00064
,
Figure 112015052111785-pat00065
,
Figure 112015052111785-pat00066
,
Figure 112015052111785-pat00067
,
Figure 112015052111785-pat00068
,
Figure 112015052111785-pat00069
,
Figure 112015052111785-pat00070
,
Figure 112015052111785-pat00071
,
Figure 112015052111785-pat00072
,
Figure 112015052111785-pat00073
,
Figure 112015052111785-pat00074
,
Figure 112015052111785-pat00075
,
Figure 112015052111785-pat00076
,
Figure 112015052111785-pat00077
,
Figure 112015052111785-pat00078
,
Figure 112015052111785-pat00079
,
Figure 112015052111785-pat00080
,
Figure 112015052111785-pat00081
,
Figure 112015052111785-pat00082
,
Figure 112015052111785-pat00083
,
Figure 112015052111785-pat00084
,
Figure 112015052111785-pat00085
,
Figure 112015052111785-pat00086
,
Figure 112015052111785-pat00087
,
Figure 112015052111785-pat00088
또는
Figure 112015052111785-pat00089
이며, 상기에서 W는 질소원자, 산소원자, 황원자 또는 Si(CH3)2이며, R1은 페닐기이며, W가 산소원자, 황원자 또는 Si(CH3)2인 경우에 R1은 부존재하며, A 및 B는 각각 독립적으로 탄소원자 또는 질소원자이며;X is
Figure 112015052111785-pat00061
,
Figure 112015052111785-pat00062
,
Figure 112015052111785-pat00063
,
Figure 112015052111785-pat00064
,
Figure 112015052111785-pat00065
,
Figure 112015052111785-pat00066
,
Figure 112015052111785-pat00067
,
Figure 112015052111785-pat00068
,
Figure 112015052111785-pat00069
,
Figure 112015052111785-pat00070
,
Figure 112015052111785-pat00071
,
Figure 112015052111785-pat00072
,
Figure 112015052111785-pat00073
,
Figure 112015052111785-pat00074
,
Figure 112015052111785-pat00075
,
Figure 112015052111785-pat00076
,
Figure 112015052111785-pat00077
,
Figure 112015052111785-pat00078
,
Figure 112015052111785-pat00079
,
Figure 112015052111785-pat00080
,
Figure 112015052111785-pat00081
,
Figure 112015052111785-pat00082
,
Figure 112015052111785-pat00083
,
Figure 112015052111785-pat00084
,
Figure 112015052111785-pat00085
,
Figure 112015052111785-pat00086
,
Figure 112015052111785-pat00087
,
Figure 112015052111785-pat00088
or
Figure 112015052111785-pat00089
And, in the above W is a second nitrogen atom, an oxygen atom, a sulfur atom, or Si (CH 3), R1 is a phenyl group, and R1 is absent, and if W is an oxygen atom, a sulfur atom, or Si (CH 3) 2, A and B are each independently a carbon atom or a nitrogen atom;

Y는 질소 또는 탄소원자이며, Y 중 적어도 하나는 질소원자이며;Y is a nitrogen or carbon atom, and at least one of Y is a nitrogen atom;

Z는 단순결합이거나, 부존재이며; Z is a simple bond or absent;

R2 및 R3는 수소원자이다.R2 and R3 are hydrogen atoms.

본 발명의 유기발광화합물은 인광 녹색 호스트 물질로서 유용하게 사용될 수 있다. The organic luminescent compound of the present invention can be usefully used as a phosphorescent green host material.


본 발명의 유기발광화합물은 하기 [제1표군(群)]에 나타낸 화학구조를 가질 수 있다.The organic luminescent compound of the present invention may have the chemical structure shown in the following [first group (s)].

[제1표군(群)][First group (group)]

Figure 112015052111785-pat00090
Figure 112015052111785-pat00091
Figure 112015052111785-pat00092
Figure 112015052111785-pat00093

Figure 112015052111785-pat00090
Figure 112015052111785-pat00091
Figure 112015052111785-pat00092
Figure 112015052111785-pat00093

본 발명은 또한,The present invention also relates to

음극과 양극 사이에 적어도 발광층을 포함하는 일층 또는 복수층으로 이루어지는 유기 박막층이 협지되어 있는 유기전기발광소자에 있어서, An organic electroluminescent device in which an organic thin film layer composed of one layer or a plurality of layers including at least a light emitting layer is sandwiched between a cathode and an anode,

상기 유기 박막층 중 적어도 1층이 본 발명의 유기발광화합물을 1종 단독으로 또는 2종 이상의 조합으로 함유하는 것을 특징으로 하는 유기전기발광소자에 관한 것이다.Wherein at least one of the organic thin film layers contains the organic electroluminescent compound of the present invention singly or in combination of two or more thereof.

상기 유기발광화합물은 인광 녹색 호스트 물질로서 유기전기발광소자에 포함될 수 있다. The organic light emitting compound may be included in the organic electroluminescent device as a phosphorescent green host material.

상기 유기전기발광소자는 The organic electroluminescent device

양극, 정공주입층, 정공수송층, 발광층, 전자수송층, 전자주입층 및 음극이 이 순서대로 적층된 구조를 가질 수 있다.An anode, a hole injecting layer, a hole transporting layer, a light emitting layer, an electron transporting layer, an electron injecting layer, and a cathode stacked in this order.

이하에서, 본 발명의 유기전기발광소자에 대하여 예를 들어 설명한다. 그러나, 하기에 예시된 내용이 본 발명의 유기전기발광소자를 한정하는 것은 아니다.Hereinafter, the organic electroluminescent device of the present invention will be described by way of example. However, the following examples do not limit the organic electroluminescent device of the present invention.

본 발명의 유기전기발광소자는 양극(정공주입전극), 정공주입층(HIL) 및/또는 정공수송층(HTL), 발광층(EML) 및 음극(전자주입전극)이 순차적으로 적층된 구조를 가질 수 있으며, 바람직하게는, 양극과 발광층 사이에 전자차단층(EBL)을, 그리고 음극과 발광층 사이에 전자수송층(ETL), 전자주입층(EIL) 또는 정공차단층(HBL)을 추가로 포함할 수 있다.The organic electroluminescent device of the present invention may have a structure in which a cathode (a hole injection electrode), a hole injection layer (HIL) and / or a hole transport layer (HTL), a light emitting layer (EML) Preferably, an electron blocking layer (EBL) may be additionally provided between the anode and the light emitting layer, and an electron transport layer (ETL), an electron injection layer (EIL) or a hole blocking layer (HBL) have.

본 발명에 따른 유기전기발광소자의 제조방법으로는, 먼저 기판 표면에 양극용 물질을 통상적인 방법으로 코팅하여 양극을 형성한다. 이때, 사용되는 기판은 투명성, 표면 평활성, 취급 용이성 및 방수성이 우수한 유리기판 또는 투명 플라스틱 기판이 바람직하다. 또한, 양극용 물질로는 투명하고 전도성이 우수한 산화인듐주석(ITO), 산화인듐아연(IZO), 산화주석(SnO2), 산화아연(ZnO) 등이 사용될 수 있다.In the method of manufacturing an organic electroluminescence device according to the present invention, a cathode material is coated on the surface of a substrate by a conventional method to form a cathode. At this time, the substrate to be used is preferably a glass substrate or a transparent plastic substrate having excellent transparency, surface smoothness, ease of handling, and waterproofness. As the material for the positive electrode, indium tin oxide (ITO), indium zinc oxide (IZO), tin oxide (SnO2), zinc oxide (ZnO) and the like which are transparent and excellent in conductivity may be used.

다음으로, 상기 양극 표면에 정공주입층(HIL) 물질을 통상적인 방법으로 진공 열증착 또는 스핀 코팅하여 정공주입층을 형성한다. 이러한 정공주입층 물질로는 구리프탈로시아닌(CuPc), 4,4',4"-트리스(3-메틸페닐아미노)트리페닐아민(m-MTDATA), 4,4',4"-트리스(3-메틸페닐아미노)페녹시벤젠(m-MTDAPB), 스타버스트(starburst)형 아민류인 4,4',4"-트리(N-카바졸릴)트리페닐아민(TCTA), 4,4',4"-트리스(N-(2-나프틸)-N-페닐아미노)-트리페닐아민(2-TNATA) 또는 이데미츠사(Idemitsu)에서 구입가능한 IDE406을 예로 들 수 있다.Next, a hole injection layer (HIL) material is formed on the surface of the anode by vacuum thermal deposition or spin coating using a conventional method. Examples of such hole injection layer materials include copper phthalocyanine (CuPc), 4,4 ', 4 "-tris (3-methylphenylamino) triphenylamine (m-MTDATA), 4,4' Amino) phenoxybenzene (m-MTDAPB), starburst type amines such as 4,4 ', 4 "-tri (N-carbazolyl) triphenylamine (TCTA), 4,4' Triphenylamine (2-TNATA) or IDE406 available from Idemitsu, for example.

상기 정공주입층 표면에 정공수송층(HTL) 물질을 통상적인 방법으로 진공 열증착 또는 스핀 코팅하여 정공수송층을 형성한다. 이때, 정공수송층 물질로는 비스(N-(1-나프틸-n-페닐))벤지딘(α-NPD), N,N'-다이(나프탈렌-1-일)-N,N'-바이페닐-벤지딘(NPB) 또는 N,N'-바이페닐-N,N'-비스(3-메틸페닐)-1,1'-바이페닐-4,4'-다이아민(TPD)을 예로 들 수 있다.A hole transport layer (HTL) material is vacuum-deposited or spin coated on the surface of the hole injection layer by a conventional method to form a hole transport layer. In this case, the hole transport layer material may be at least one selected from the group consisting of bis (N- (1-naphthyl-n-phenyl)) benzidine (? -NPD), N, -Benzidine (NPB) or N, N'-biphenyl-N, N'-bis (3-methylphenyl) -1,1'-biphenyl-4,4'-diamine (TPD).

상기 정공수송층 표면에 발광층(EML) 물질을 통상적인 방법으로 진공 열증착 또는 스핀 코팅하여 발광층을 형성한다. 이때, 사용되는 발광층 물질 중 단독 발광물질 또는 발광 호스트 물질은 녹색의 경우 본 발명의 유기발광화합물이 인광 녹색 호스트 물질로 사용될 수 있으며, 이 밖에 트리스(8-하이드록시퀴놀리놀라토)알루미늄(Alq3)가, 청색의 경우 Balq(8-하이드록시퀴놀린베릴륨염), DPVBi(4,4'-비스(2,2-바이페닐에테닐)-1,1'-바이페닐)계열, 스파이로(Spiro)물질, 스파이로-DPVBi(스파이로-4,4'-비스(2,2-바이페닐에테닐)-1,1'-바이페닐), LiPBO(2-(2-벤조옥사졸릴)-페놀 리튬염), 비스(바이페닐비닐)벤젠, 알루미늄-퀴놀린 금속착체, 이미다졸, 티아졸 및 옥사졸의 금속착체 등이 있다.A light emitting layer (EML) material is formed on the surface of the hole transport layer by vacuum thermal deposition or spin coating using a conventional method. In this case, the organic luminescent compound of the present invention may be used as a phosphorescent green host material in a case where the single luminescent material or the luminescent host material used in the luminescent layer material used is green. In addition, tris (8-hydroxyquinolinolato) aluminum ), Blue (Balq (8-hydroxyquinoline beryllium salt), DPVBi (4,4'-bis (2,2-biphenylethenyl) -1,1'-biphenyl) series, Spiro ) Material, a spiro-DPVBi (spiro-4,4'-bis (2,2-biphenylethenyl) -1,1'-biphenyl), LiPBO (2- (2-benzoxazolyl) Lithium salts), bis (biphenylvinyl) benzene, aluminum-quinoline metal complexes, imidazole, thiazole and oxazole metal complexes.

발광층 물질 중 발광 호스트와 함께 사용될 수 있는 도펀트(dopant)의 경우 형광 도펀트로서 이데미츠사(Idemitsu)에서 구입 가능한 IDE102, IDE105, 인광 도펀트로는 트리스(2-페닐피리딘)이리듐(III)(Ir(ppy)3), 이리듐(III)비스[(4,6-다이플루오로페닐)피리디나토-N,C-2']피콜린산염(FIrpic) (참조문헌[Chihaya Adachi et al., Appl. Phys. Lett., 2001, 79, 3082-3084]), 플라티늄(II)옥타에틸포르피린(PtOEP), TBE002(코비온사) 등을 사용할 수 있다.Among the light emitting layer materials, IDE102 and IDE105 available from Idemitsu as phosphorescent dopants and tris (2-phenylpyridine) iridium (III) (Ir (ppy ) 3), iridium (III) bis [(4,6-difluorophenyl) pyridinate-N, C-2 '] picolinate (FIrpic) (Chihaya Adachi et al., Appl. Phys Platy (II) octaethylporphyrin (PtOEP), TBE002 (Cobion), etc. may be used.

상기 발광층 표면에 전자수송층(ETL) 물질을 통상적인 방법으로 진공 열증착 또는 스핀 코팅하여 전자수송층을 형성한다. 이때, 사용되는 전자수송층 물질의 경우 특별히 제한되지 않으며, 바람직하게는 트리스(8-하이드록시퀴놀리놀라토)알루미늄(Alq3)을 사용할 수 있다.An electron transport layer (ETL) material is formed on the surface of the light emitting layer by vacuum thermal deposition or spin coating using a conventional method. In this case, the electron transporting material to be used is not particularly limited, and tris (8-hydroxyquinolinolato) aluminum (Alq3) can be preferably used.

선택적으로는, 발광층과 전자수송층 사이에 정공차단층(HBL)을 추가로 형성하고 발광층에 인광 도펀트를 함께 사용함으로써, 삼중항 여기자 또는 정공이 전자수송층으로 확산되는 현상을 방지할 수 있다. Alternatively, by further forming a hole blocking layer (HBL) between the light emitting layer and the electron transporting layer and using a phosphorescent dopant together with the light emitting layer, it is possible to prevent the phenomenon that the triplet excitons or holes are diffused into the electron transporting layer.

정공차단층의 형성은 정공차단층 물질을 통상적인 방법으로 진공 열증착 및 스핀 코팅하여 실시할 수 있으며, 정공차단층 물질의 경우 특별히 제한되지는 않으나, 바람직하게는 (8-하이드록시퀴놀리놀라토)리튬(Liq), 비스(8-하이드록시-2-메틸퀴놀리놀나토)-알루미늄비페녹사이드(BAlq), 바쏘쿠프로인 (bathocuproine, BCP) 및 LiF 등을 사용할 수 있다.The hole blocking layer can be formed by vacuum thermal deposition and spin coating using a hole blocking layer material in a conventional manner. In the case of the hole blocking layer material, there is no particular limitation, but (8-hydroxyquinolinolato Lithium biphenoxide (BAlq), bathocuproine (BCP), LiF, etc. may be used as the lithium salt of lithium (Li), bis (8-hydroxy-2-methylquinolinonato)

상기 전자수송층 표면에 전자주입층(EIL) 물질을 통상적인 방법으로 진공 열증착 또는 스핀 코팅하여 전자주입층을 형성한다. 이때, 사용되는 전자주입층 물질의 경우 특별히 제한되지 않으며, 바람직하게는 LiF, Liq, Li2O, BaO, NaCl, CsF 등의 물질을 사용할 수 있다.An electron injection layer (EIL) material is formed on the surface of the electron transport layer by vacuum thermal deposition or spin coating using a conventional method. In this case, the material of the electron injection layer to be used is not particularly limited, and preferably materials such as LiF, Liq, Li2O, BaO, NaCl, and CsF can be used.

마지막으로, 상기 전자주입층 표면에 음극용 물질을 통상적인 방법으로 진공 열증착하여 음극을 형성한다.Finally, a negative electrode is formed on the surface of the electron injecting layer by vacuum thermal deposition using a conventional method.

이때, 사용되는 음극용 물질로는 리튬(Li), 알루미늄(Al), 알루미늄-리튬(Al-Li), 칼슘(Ca), 마그네슘(Mg), 마그네슘-인듐(Mg-In), 마그네슘-은(Mg-Ag) 등이 사용될 수 있다. 또한, 전면발광 유기전기발광소자의 경우 산화인듐주석(ITO) 또는 산화인듐아연(IZO)를 사용하여 빛이 투과할 수 있는 투명한 음극을 형성할 수도 있다.At this time, as the negative electrode material to be used, lithium, aluminum, aluminum-lithium, calcium, magnesium, (Mg-Ag) or the like may be used. In the case of a top emission organic electroluminescent device, indium tin oxide (ITO) or indium zinc oxide (IZO) may be used to form a transparent cathode capable of transmitting light.

본 발명에 따른 유기 전계발광 소자는 상술한 바와 같은 순서, 즉 양극/정공주입층/정공수송층/발광층/정공차단층/전자수송층/전자주입층/음극 순으로 제조하여도 되고, 그 반대로 음극/전자주입층/전자수송층/정공차단층/발광층/정공수송층/정공주입층/양극의 순서로 제조하여도 무방하다.The organic electroluminescent device according to the present invention may be manufactured in the order as described above, that is, in the order of anode / hole injection layer / hole transport layer / light emitting layer / hole blocking layer / electron transport layer / electron injection layer / cathode, Electron injection layer / electron transporting layer / hole blocking layer / light emitting layer / hole transporting layer / hole injecting layer / anode.

이하에서, 본 발명의 화합물들의 합성방법을 대표적인 예를 들어 하기에 설명한다. 그러나, 본 발명의 화합물들의 합성방법이 하기 예시된 방법으로 한정되는 것은 아니며, 본 발명의 화합물들은 하기에 예시된 방법과 이 분야의 공지의 방법에 의해 제조될 수 있다.Hereinafter, a method of synthesizing the compounds of the present invention will be described with reference to representative examples. However, the method of synthesizing the compounds of the present invention is not limited to the following exemplified methods, and the compounds of the present invention can be produced by the methods exemplified below and by methods known in the art.

화합물 [1]의 합성Synthesis of Compound [1]

[반응식 1] [Reaction Scheme 1]

Figure 112015052111785-pat00094
Figure 112015052111785-pat00094

중간체 화합물 [1-1]의 제조Preparation of intermediate compound [1-1]

250mL 반응플라스크에 2,7-디브로모-9,9'-스피로비[플루오렌] 10.0g (21.09mmol), 11-페닐-11,12-디히드로인돌로[2,3-a]카바졸 7.71g(23.19mmol), 팔라듐(II)아세테이트 47mg (0.21mmol), 트리터트부틸포스핀(50%) 0.2mL (0.42mmol), 터트부톡시 나트륨 3.04g (31.63mmol)을 투입하고 질소기류하에서 톨루엔 100mL로 12시간 동안 환류 교반시킨다. 반응종결 후 실온까지 천천히 냉각한 다음 반응액을 포화 염화암모늄 수용액에 붓고 에틸아세테이트로 추출한다. 유기층을 분리하고 무수황산 마그네슘으로 건조하여 여과한다. 여과액은 감압농축하고 컬럼크로마토그라프로 분리정제하여 흰색고체의 중간체화합물[1-1] 7.2g(47%)를 수득하였다.In a 250 mL reaction flask, 10.0 g (21.09 mmol) of 2,7-dibromo-9,9'-spiro [fluorene], 11-phenyl-11,12-dihydroindolo [2,3- (31.63 mmol) of sodium tert-butoxide were added and the mixture was poured into a nitrogen stream Was stirred under reflux for 12 hours with 100 mL of toluene. After completion of the reaction, the reaction mixture was slowly cooled to room temperature, and then the reaction solution was poured into a saturated aqueous solution of ammonium chloride and extracted with ethyl acetate. The organic layer was separated, dried over anhydrous magnesium sulfate and filtered. The filtrate was concentrated under reduced pressure and purified by column chromatography to obtain 7.2 g (47%) of intermediate compound [1-1] as a white solid.

2구 플라스크에 [1-1] 7.0g(0.219mol), 무수테트라히드로퓨란 150ml을 넣고 -78℃에서 교반시킨다. n-부틸리튬(2.5M in hexane) 4.24mL(10.61mmol)를 동온도에서 적가시키고 30분 후에 트리메틸 보레이트 1.18ml(10.61mmol)을 첨가한다. 반응온도를 상온까지 서서히 6시간 동안 올리고 에틸아세테이트와 포화암모늄 수용액으로 추출하여 유기층을 분리하여 무수황산마그네슘으로 건조 후 여과하여 얻은 유기층을 감압농축 후 디클로로메탄과 헥산으로 재결정화하여 흰색 고체의 중간체 화합물 [1-2] 3.4g(51%)을 수득하였다.7.0 g (0.219 mol) of [1-1] and 150 ml of anhydrous tetrahydrofuran were placed in a two-neck flask, and the mixture was stirred at -78 ° C. 4.24 mL (10.61 mmol) of n-butyllithium (2.5 M in hexane) is added dropwise at this temperature and after 30 minutes 1.18 ml (10.61 mmol) of trimethylborate are added. The organic layer was separated, dried over anhydrous magnesium sulfate, and then filtered. The organic layer was concentrated under reduced pressure, and recrystallized from dichloromethane and hexane to obtain an intermediate compound of white solid 3.4 g (51%) of [1-2] was obtained.

화합물[1]의 제조Preparation of compound [1]

반응플라스크에 중간체 화합물 [1-2] 3.4g (4.92mmol), 2-클로로-4,6-디페닐-l-1,3,5-트리아진 1.45g(5.41mmol), 테트라키스(트리페닐포스핀)팔라듐 57mg(0.05mmol), 탄산칼륨 (K2CO3)1.02g(7.38mmol)을 투입하고 질소기류하에서 1,4-디옥산 100mL, 정제수 10mL 로 12시간 동안 환류 교반시킨다. 반응종결 후 실온까지 천천히 냉각한 다음 반응액을 여과한다. 여과된 고체는 정제수와 메탄올로 세척하고 디클로로메탄과 메탄올로 재결정화하여 흰색고체의 화합물[1] 2.9g(68%)를 수득하였다.To the reaction flask were added 3.4 g (4.92 mmol) of the intermediate compound [1-2], 1.45 g (5.41 mmol) of 2-chloro-4,6-diphenyl- 57 mg (0.05 mmol) of palladium and 1.02 g (7.38 mmol) of potassium carbonate (K 2 CO 3 ) were added and stirred under reflux for 12 hours with 100 mL of 1,4-dioxane and 10 mL of purified water under a nitrogen stream. After completion of the reaction, slowly cool to room temperature, and then filter the reaction solution. The filtered solid was washed with purified water and methanol, and recrystallized from dichloromethane and methanol to give 2.9 g (68%) of a white solid compound [1].

화합물 [25]의 합성Synthesis of Compound [25]

[반응식 2] [Reaction Scheme 2]

Figure 112015052111785-pat00095
Figure 112015052111785-pat00095

화합물[25]의 제조Preparation of compound [25]

화합물[1]과 동일한 방법으로 진행하여 목적화합물 [25]를 합성하였다. The objective compound [25] was synthesized by proceeding in the same manner as the compound [1].

상기 반응식 1 내지 2의 방법에 따라, 화합물 1-6 및 8-74의 화합물을 제조하였으며, 그 결과를 하기에 결과를 나타내었다.Compounds 1-6 and 8-74 were prepared according to the methods of Schemes 1 and 2 above and the results are shown below.

[[ 합성예Synthetic example 1] 화합물 [1]의 합성 1] Synthesis of Compound [1]

1H NMR (300 MHz, CDCl3):δ 8.45(d, 2H), 8.18(d, 4H), 8.02(d, 1H), 7.84~7.77(m, 4H), 7.65(d, 2H), 7.53~7.06(m, 26H) 1 H NMR (300 MHz, CDCl 3): δ 8.45 (d, 2H), 8.18 (d, 4H), 8.02 (d, 1H), 7.84 ~ 7.77 (m, 4H), 7.65 (d, 2H), 7.53 ~ 7.06 (m, 26H)

MS/FAB: 878(M+)MS / FAB: 878 (M < + & gt ; ).

[[ 합성예Synthetic example 2] 화합물 [2]의 합성 2] Synthesis of compound [2]

1H NMR (300 MHz, CDCl3):δ 8.45(d, 1H), 8.18(d, 4H), 8.02(d, 1H), 7.84~7.77(m, 3H), 7.65(d, 2H), 7.53~7.06(m, 28H) 1 H NMR (300 MHz, CDCl 3): δ 8.45 (d, 1H), 8.18 (d, 4H), 8.02 (d, 1H), 7.84 ~ 7.77 (m, 3H), 7.65 (d, 2H), 7.53 ~ 7.06 (m, 28H)

MS/FAB: 878(M+)MS / FAB: 878 (M < + & gt ; ).

[[ 합성예Synthetic example 3] 화합물 [3]의 합성 3] Synthesis of compound [3]

1H NMR (300 MHz, CDCl3):δ 8.45(d, 2H), 8.18(d, 4H), 8.02(d, 1H), 7.84~7.77(m, 4H), 7.65(d, 2H), 7.53~7.06(m, 26H) 1 H NMR (300 MHz, CDCl 3): δ 8.45 (d, 2H), 8.18 (d, 4H), 8.02 (d, 1H), 7.84 ~ 7.77 (m, 4H), 7.65 (d, 2H), 7.53 ~ 7.06 (m, 26H)

MS/FAB: 878(M+)MS / FAB: 878 (M < + & gt ; ).

[[ 합성예Synthetic example 4] 화합물 [4]의 합성 4] Synthesis of compound [4]

1H NMR (300 MHz, CDCl3):δ 9.41(s, 1H), 8.64(d, 1H), 8.45(d, 1H), 8.18(d, 4H), 7.84~7.77(m, 4H), 7.65(d, 2H), 7.53~7.06(m, 25H) 1 H NMR (300 MHz, CDCl 3): δ 9.41 (s, 1H), 8.64 (d, 1H), 8.45 (d, 1H), 8.18 (d, 4H), 7.84 ~ 7.77 (m, 4H), 7.65 (d, 2H), 7.53 ~ 7.06 (m, 25H)

MS/FAB: 879(M+)MS / FAB: 879 (M < + & gt ; ).

[[ 합성예Synthetic example 5] 화합물 [5]의 합성 5] Synthesis of compound [5]

1H NMR (300 MHz, CDCl3):δ 9.41(s, 1H), 8.64(d, 1H), 8.45(d, 1H), 8.18(d, 4H), 7.84~7.77(m, 4H), 7.65(d, 2H), 7.53~7.06(m, 25H) 1 H NMR (300 MHz, CDCl 3): δ 9.41 (s, 1H), 8.64 (d, 1H), 8.45 (d, 1H), 8.18 (d, 4H), 7.84 ~ 7.77 (m, 4H), 7.65 (d, 2H), 7.53 ~ 7.06 (m, 25H)

MS/FAB: 879(M+)MS / FAB: 879 (M < + & gt ; ).

[[ 합성예Synthetic example 6] 화합물 [6]의 합성 6] Synthesis of compound [6]

1H NMR (300 MHz, CDCl3):δ 9.61(s, 1H), 8.84(s, 1H), 8.65(s, 1H), 8.38(s, 4H), 8.04~7.97(m, 4H), 7.85(s, 2H), 7.61~7.26(m, 25H) 1 H NMR (300 MHz, CDCl 3): δ 9.61 (s, 1H), 8.84 (s, 1H), 8.65 (s, 1H), 8.38 (s, 4H), 8.04 ~ 7.97 (m, 4H), 7.85 (s, 2H), 7.61 ~ 7.26 (m, 25H)

MS/FAB: 879(M+)MS / FAB: 879 (M < + & gt ; ).

[[ 합성예Synthetic example 8] 화합물 [8]의 합성 8] Synthesis of compound [8]

1H NMR (300 MHz, CDCl3):δ 8.65(s, 2H), 8.38(s, 4H), 8.22(s, 1H), 8.04~7.97(m, 4H), 7.85(s, 2H), 7.68~7.26(m, 26H) 1 H NMR (300 MHz, CDCl 3): δ 8.65 (s, 2H), 8.38 (s, 4H), 8.22 (s, 1H), 8.04 ~ 7.97 (m, 4H), 7.85 (s, 2H), 7.68 ~ 7.26 (m, 26H)

MS/FAB: 878(M+)MS / FAB: 878 (M < + & gt ; ).

[[ 합성예Synthetic example 9] 화합물 [9]의 합성 9] Synthesis of compound [9]

1H NMR (300 MHz, CDCl3):δ 8.38(s, 4H), 8.03~7.97(m, 4H), 7.85~7.82(m, 4H), 7.73~7 1 H NMR (300 MHz, CDCl 3 ):? 8.38 (s, 4H), 8.03-7.97 (m, 4H), 7.85-7.82

.44(m, 18H), 7.29~7.26(m, 5H), 6.95(t, 2H), 2.91(s, 4H) (M, 2H), 2.45 (s, 3H)

MS/FAB: 880(M+)MS / FAB: 880 (M < + & gt ; ).

[[ 합성예Synthetic example 10] 화합물 [10]의 합성 10] Synthesis of compound [10]

1H NMR (300 MHz, CDCl3):δ 8.38(s, 4H), 8.03~7.97(m, 4H), 7.85~7.82(m, 4H), 7.68~7.45(m, 18H), 7.29~7.26(m, 5H), 6.95(t, 2H), 2.39(s, 6H) 1 H NMR (300 MHz, CDCl 3 ):? 8.38 (s, 4H), 8.03-7.97 (m, 4H), 7.85-7.82 (m, 4H), 7.68-7.45 m, SH), 6.95 (t, 2H), 2.39 (s, 6H)

MS/FAB: 882(M+)MS / FAB: 882 (M < + & gt ; ).

[[ 합성예Synthetic example 11] 화합물 [11]의 합성 11] Synthesis of compound [11]

1H NMR (300 MHz, CDCl3):δ 8.45(d, 1H), 8.18(d, 4H), 8.04(d, 1H), 7.83~7.77(m, 3H), 7.65(d, 2H), 7.53~7.06(m, 24H), 2.19~2.18(m, 6H) 1 H NMR (300 MHz, CDCl 3): δ 8.45 (d, 1H), 8.18 (d, 4H), 8.04 (d, 1H), 7.83 ~ 7.77 (m, 3H), 7.65 (d, 2H), 7.53 ~ 7.06 (m, 24H), 2.19-2.18 (m, 6H)

MS/FAB: 856(M+)MS / FAB: < / RTI & gt ; 856 (M + )

[[ 합성예Synthetic example 12] 화합물 [12]의 합성 12] Synthesis of compound [12]

1H NMR (300 MHz, CDCl3):δ 8.45(d, 1H), 8.33(d, 1H), 8.18(m, 4H), 7.84~7.77(m, 4H), 7.65(d, 2H), 7.53~7.06(m, 24H), 6.42(d, 1H) 1 H NMR (300 MHz, CDCl 3): δ 8.45 (d, 1H), 8.33 (d, 1H), 8.18 (m, 4H), 7.84 ~ 7.77 (m, 4H), 7.65 (d, 2H), 7.53 ~ 7.06 (m, 24H), 6.42 (d, IH)

MS/FAB: 827(M+)MS / FAB: 827 (M < + & gt ; ).

[[ 합성예Synthetic example 13] 화합물 [13]의 합성 13] Synthesis of Compound [13]

1H NMR (300 MHz, CDCl3):δ 8.45(d, 1H), 8.18(d, 4H), 7.84~7.77(m, 3H), 7.65(d, 2H), 7.53(d, 1H), 7.46~7.05(m, 23H), 6.67(t, 1H), 4.04(m, 2H), 2.95(m, 2H) 1 H NMR (300 MHz, CDCl 3 ):? 8.45 (d, 1 H), 8.18 (d, 4H), 7.84-7.77 2H), 2.95 (m, 2H), 7.05 (m, 2H)

MS/FAB: 829(M+) MS / FAB: 829 (M < + & gt ; ).

[[ 합성예Synthetic example 14] 화합물 [14]의 합성 14] Synthesis of compound [14]

1H NMR (300 MHz, CDCl3):δ 8.45(d, 1H), 8.33(d, 1H), 8.18(m, 4H), 7.84~7.77(m, 4H), 7.65(d, 2H), 7.50~7.06(m, 24H), 6.42(d, 1H) 1 H NMR (300 MHz, CDCl 3): δ 8.45 (d, 1H), 8.33 (d, 1H), 8.18 (m, 4H), 7.84 ~ 7.77 (m, 4H), 7.65 (d, 2H), 7.50 ~ 7.06 (m, 24H), 6.42 (d, IH)

MS/FAB: 827(M+) MS / FAB: 827 (M < + & gt ; ).

[[ 합성예Synthetic example 15] 화합물 [15]의 합성 15] Synthesis of compound [15]

1H NMR (300 MHz, CDCl3):δ 8.18(d, 4H), 7.84~7.77(m, 4H), 7.65(d, 2H), 7.53~7.23(m, 17H), 7.09~7.06(m, 5H), 6.77~6.70(m, 2H), 6.01(s, 1H), 2.04(s, 3H), 1.94(s, 3H) 1 H NMR (300 MHz, CDCl 3): δ 8.18 (d, 4H), 7.84 ~ 7.77 (m, 4H), 7.65 (d, 2H), 7.53 ~ 7.23 (m, 17H), 7.09 ~ 7.06 (m, 2H), 6.01 (s, 1H), 2.04 (s, 3H), 1.94 (s, 3H)

MS/FAB: 832(M+)MS / FAB: 832 (M < + & gt ; ) [

[[ 합성예Synthetic example 16] 화합물 [16]의 합성 16] Synthesis of compound [16]

1H NMR (300 MHz, CDCl3):δ 8.18(m, 4H), 7.83~7.77(m, 4H), 7.65(m, 2H), 7.53~7.25(m, 23H), 6.77~6.70 (m, 2H), 6.38(d, 1H), 6.31(t, 1H) 1 H NMR (300 MHz, CDCl 3 ):? 8.18 (m, 4H), 7.83-7.77 (m, 4H), 7.65 (m, 2H), 7.53-7.25 2H), 6.38 (d, 1 H), 6.31 (t, 1 H)

MS/FAB: 804(M+)MS / FAB: 804 (M < + & gt ; ).

[[ 합성예Synthetic example 17] 화합물 [17]의 합성 17] Synthesis of compound [17]

1H NMR (300 MHz, CDCl3):δ 8.45(d, 1H), 8.35(d, 1H), 8.28(m, 4H), 7.95~7.74(m, 5H), 7.65(m, 2H), 7.50~7.15(m, 21H) 1 H NMR (300 MHz, CDCl 3): δ 8.45 (d, 1H), 8.35 (d, 1H), 8.28 (m, 4H), 7.95 ~ 7.74 (m, 5H), 7.65 (m, 2H), 7.50 ~ 7.15 (m, 21H)

MS/FAB: 819(M+)MS / FAB: 819 (M < + & gt ; ).

[[ 합성예Synthetic example 18] 화합물 [18]의 합성 18] Synthesis of compound [18]

1H NMR (300 MHz, CDCl3):δ 8.45(d, 1H), 8.35(d, 1H), 8.18(m, 4H), 7.98(d, 1H), 7.88~7.65(m, 7H), 7.53(d, 1H), 7.41~7.15(m, 19H) 1 H NMR (300 MHz, CDCl 3): δ 8.45 (d, 1H), 8.35 (d, 1H), 8.18 (m, 4H), 7.98 (d, 1H), 7.88 ~ 7.65 (m, 7H), 7.53 (d, 1 H), 7.41-7.15 (m, 19 H)

MS/FAB: 819(M+) MS / FAB: 819 (M < + & gt ; ).

[[ 합성예Synthetic example 19] 화합물 [19]의 합성 19] Synthesis of compound [19]

1H NMR (300 MHz, CDCl3):δ 8.45(d, 1H), 8.35(d, 1H), 8.18(m, 4H), 7.88~7.76(m, 5H), 7.68(m, 3H), 7.53(d, 1H), 7.46~7.15(m, 19H)
1 H NMR (300 MHz, CDCl 3 ):? 8.45 (d, IH), 8.35 (d, IH), 8.18 (m, 4H), 7.88-7. (d, 1 H), 7.46-7.15 (m, 19 H)

MS/FAB: 819(M+) MS / FAB: 819 (M < + & gt ; ).

[[ 합성예Synthetic example 20] 화합물 [20]의 합성 20] Synthesis of compound [20]

1H NMR (300 MHz, CDCl3):δ 8.45(d, 1H), 8.18(m, 5H), 7.88~7.76(m, 5H), 7.65(m, 2H), 7.51~7.15(m, 21H), 0.56(s, 6H) 1 H NMR (300 MHz, CDCl 3): δ 8.45 (d, 1H), 8.18 (m, 5H), 7.88 ~ 7.76 (m, 5H), 7.65 (m, 2H), 7.51 ~ 7.15 (m, 21H) , 0.56 (s, 6H)

MS/FAB: 845(M+)MS / FAB: 845 (M < + & gt ; ).

[[ 합성예Synthetic example 21] 화합물 [21]의 합성 21] Synthesis of Compound [21]

1H NMR (300 MHz, CDCl3):δ 8.54(d, 1H), 8.27(d, 4H), 7.93~7.86(m, 5H), 7.74~7.71(m, 3H), 7.62~7.15(m, 21H), 0.65(s, 6H) 1 H NMR (300 MHz, CDCl 3 ):? 8.54 (d, 1H), 8.27 (d, 4H), 7.93-7.86 (m, 5H), 7.74-7.71 21H), 0.65 (s, 6H)

MS/FAB: 845(M+)MS / FAB: 845 (M < + & gt ; ).

[[ 합성예Synthetic example 22] 화합물 [22]의 합성 22] Synthesis of compound [22]

1H NMR (300 MHz, CDCl3):δ 8.54(d, 1H), 8.27(d, 4H), 7.93~7.86(m, 5H), 7.74(d, 2H), 7.65~7.15(m, 22H), 1 H NMR (300 MHz, CDCl 3): δ 8.54 (d, 1H), 8.27 (d, 4H), 7.93 ~ 7.86 (m, 5H), 7.74 (d, 2H), 7.65 ~ 7.15 (m, 22H) ,

MS/FAB: 802(M+)MS / FAB: 802 (M < + & gt ; ).

[[ 합성예Synthetic example 23] 화합물 [23]의 합성 23] Synthesis of compound [23]

1H NMR (300 MHz, CDCl3):δ 8.54(d, 1H), 8.27(d, 4H), 8.15(d, 2H), 8.04(d, 1H), 7.93~7.85(m, 4H), 7.77~7.15(m, 24H) 1 H NMR (300 MHz, CDCl 3): δ 8.54 (d, 1H), 8.27 (d, 4H), 8.15 (d, 2H), 8.04 (d, 1H), 7.93 ~ 7.85 (m, 4H), 7.77 ~ 7.15 (m, 24H)

MS/FAB: 869(M+)MS / FAB: 869 (M < + & gt ; ).

[[ 합성예Synthetic example 24] 화합물 [24]의 합성 24] Synthesis of compound [24]

1H NMR (300 MHz, CDCl3):δ 8.44(d, 1H), 8.27(d, 4H), 8.15(d, 2H), 8.04~7.86(m, 4H), 7.74~7.33(m, 20H), 7.18~7.15(m, 5H) 1 H NMR (300 MHz, CDCl 3): δ 8.44 (d, 1H), 8.27 (d, 4H), 8.15 (d, 2H), 8.04 ~ 7.86 (m, 4H), 7.74 ~ 7.33 (m, 20H) , 7.18-7.15 (m, 5H)

MS/FAB: 869(M+)MS / FAB: 869 (M < + & gt ; ).

[[ 합성예Synthetic example 25] 화합물 [25]의 합성 25] Synthesis of compound [25]

1H NMR (300 MHz, CDCl3):δ 8.54(d, 2H), 8.27(d, 4H), 8.11(d, 1H), 7.93~7.74(m, 6H), 7.57~7.06(m, 26H) 1 H NMR (300 MHz, CDCl 3): δ 8.54 (d, 2H), 8.27 (d, 4H), 8.11 (d, 1H), 7.93 ~ 7.74 (m, 6H), 7.57 ~ 7.06 (m, 26H)

MS/FAB: 878(M+)MS / FAB: 878 (M < + & gt ; ).

[[ 합성예Synthetic example 26] 화합물 [26]의 합성 26] Synthesis of compound [26]

1H NMR (300 MHz, CDCl3):δ 8.54(m, 1H), 8.27(m, 4H), 8.11(m, 1H), 7.93~7.74(m, 5H), 7.62~7.16(m, 28H) 1 H NMR (300 MHz, CDCl 3 ):? 8.54 (m, 1H), 8.27 (m, 4H), 8.11

MS/FAB: 878(M+)MS / FAB: 878 (M < + & gt ; ).

[[ 합성예Synthetic example 27] 화합물 [27]의 합성 27] Synthesis of Compound [27]

1H NMR (300 MHz, CDCl3):δ 8.54(m, 2H), 8.27(m, 4H), 8.11(m, 1H), 7.93~7.74(m, 6H), 7.57~7.16(m, 26H) 1 H NMR (300 MHz, CDCl 3 ):? 8.54 (m, 2H), 8.27 (m, 4H), 8.11

MS/FAB: 878(M+)MS / FAB: 878 (M < + & gt ; ).

[[ 합성예Synthetic example 28] 화합물 [28]의 합성 28] Synthesis of compound [28]

1H NMR (300 MHz, CDCl3):δ 9.50(m, 1H), 8.73(m, 1H), 8.54(m, 1H), 8.27(m, 4H), 7.93~7.74(m, 6H), 7.57~7.18(m, 25H) 1 H NMR (300 MHz, CDCl 3 ):? 9.50 (m, IH), 8.73 (m, IH), 8.54 ~ 7.18 (m, 25H)

MS/FAB: 879(M+)MS / FAB: 879 (M < + & gt ; ).

[[ 합성예Synthetic example 29] 화합물 [29]의 합성 29] Synthesis of compound [29]

1H NMR (300 MHz, CDCl3):δ 9.50(m, 1H), 8.73(m, 1H), 8.54(m, 1H), 8.27(m, 4H), 7.93~7.74(m, 6H), 7.57(m, 25H) 1 H NMR (300 MHz, CDCl 3 ):? 9.50 (m, IH), 8.73 (m, IH), 8.54 (m, 25H)

MS/FAB: 879(M+)MS / FAB: 879 (M < + & gt ; ).

[[ 합성예Synthetic example 30] 화합물 [30]의 합성 30] Synthesis of compound [30]

1H NMR (300 MHz, CDCl3):δ 8.54~8.53(m, 4H), 8.27(m, 4H), 7.86~7.24(m, 33H) 1 H NMR (300 MHz, CDCl 3 ):? 8.54 to 8.53 (m, 4H), 8.27 (m, 4H), 7.86-7.24

MS/FAB: 928(M+)MS / FAB: 928 (M < + & gt ; ).

[[ 합성예Synthetic example 31] 화합물 [31]의 합성 31] Synthesis of Compound [31]

1H NMR (300 MHz, CDCl3):δ 8.55(d, 2H), 8.28(d, 4H), 8.12(d, 1H), 7.94~7.75(m, 6H), 7.58~7.07(m, 26H) 1 H NMR (300 MHz, CDCl 3): δ 8.55 (d, 2H), 8.28 (d, 4H), 8.12 (d, 1H), 7.94 ~ 7.75 (m, 6H), 7.58 ~ 7.07 (m, 26H)

MS/FAB: 878(M+)MS / FAB: 878 (M < + & gt ; ).

[[ 합성예Synthetic example 32] 화합물 [32]의 합성 32] Synthesis of Compound [32]

1H NMR (300 MHz, CDCl3):δ 8.28(d, 4H), 7.93~7.72(m, 8H), 7.51~7.34(m, 18H), 7.19~7.07(m, 5H), 6.85(t, 2H), 2.81(s, 4H) 1 H NMR (300 MHz, CDCl 3): δ 8.28 (d, 4H), 7.93 ~ 7.72 (m, 8H), 7.51 ~ 7.34 (m, 18H), 7.19 ~ 7.07 (m, 5H), 6.85 (t, 2H), 2.81 (s, 4H)

MS/FAB: 880(M+)MS / FAB: 880 (M < + & gt ; ).

[[ 합성예Synthetic example 33] 화합물 [33]의 합성 33] Synthesis of compound [33]

1H NMR (300 MHz, CDCl3):δ 8.28(d, 4H), 7.93~7.72(m, 8H), 7.58~7.34(m, 18H), 7.19~7.07(m, 5H), 6.85(t, 2H), 2.29(s, 6H) 1 H NMR (300 MHz, CDCl 3 ):? 8.28 (d, 4H), 7.93-7.72 (m, 8H), 7.58-7.34 (m, 18H), 7.19-7.07 2H), 2.29 (s, 6H)

MS/FAB: 882(M+)MS / FAB: 882 (M < + & gt ; ).

[[ 합성예Synthetic example 34] 화합물 [34]의 합성 34] Synthesis of compound [34]

1H NMR (300 MHz, CDCl3):δ 8.28(d, 4H), 7.94~7.75(m, 8H), 7.58~7.33(m, 18H), 7.19~7.07(m, 5H), 6.87(t, 2H), 6.80(s, 2H) 1 H NMR (300 MHz, CDCl 3): δ 8.28 (d, 4H), 7.94 ~ 7.75 (m, 8H), 7.58 ~ 7.33 (m, 18H), 7.19 ~ 7.07 (m, 5H), 6.87 (t, 2H), [delta] 6.80 (s, 2H)

MS/FAB: 854(M+)MS / FAB: < / RTI & gt ; 854 (M + )

[[ 합성예Synthetic example 35] 화합물 [35]의 합성 35] Synthesis of Compound [35]

1H NMR (300 MHz, CDCl3):δ 8.55(d, 1H), 8.28(d, 4H), 8.14(d, 1H), 7.94~7.75(m, 5H), 7.59~7.07(m, 24H), 2.29(d, 6H) 1 H NMR (300 MHz, CDCl 3): δ 8.55 (d, 1H), 8.28 (d, 4H), 8.14 (d, 1H), 7.94 ~ 7.75 (m, 5H), 7.59 ~ 7.07 (m, 24H) , 2.29 (d, 6H)

MS/FAB: 856(M+)MS / FAB: < / RTI & gt ; 856 (M + )

[[ 합성예Synthetic example 36] 화합물 [36]의 합성 36] Synthesis of Compound [36]

1H NMR (300 MHz, CDCl3):δ 8.45(d, 1H), 8.33(d, 1H), 8.18(m, 4H), 7.84~7.65(m, 6H), 7.50~7.07(m, 24H), 6.42(d, 1H) 1 H NMR (300 MHz, CDCl 3): δ 8.45 (d, 1H), 8.33 (d, 1H), 8.18 (m, 4H), 7.84 ~ 7.65 (m, 6H), 7.50 ~ 7.07 (m, 24H) , 6.42 (d, 1 H)

MS/FAB: 828(M+)MS / FAB: 828 (M < + & gt ; ).

[[ 합성예Synthetic example 37] 화합물 [37]의 합성 37] Synthesis of Compound [37]

1H NMR (300 MHz, CDCl3):δ 8.45(d, 1H), 8.18(m, 4H), 7.84~7.65(m, 5H), 7.47~7.05(m, 24H), 6.67(t, 1H), 4.04(t, 2H), 2.95(t, 2H) 1 H NMR (300 MHz, CDCl 3 ):? 8.45 (d, 1H), 8.18 (m, 4H), 7.84-7.65 , 4.04 (t, 2 H), 2.95 (t, 2 H)

MS/FAB: 830(M+)MS / FAB: 830 (M < + & gt ; ) [

[[ 합성예Synthetic example 38] 화합물 [38]의 합성 38] Synthesis of Compound [38]

1H NMR (300 MHz, CDCl3):δ 8.45(d, 1H), 8.33(d, 1H), 8.18(m, 4H), 7.84~7.65(m, 6H), 7.50~7.06(m, 24H), 6.42(t, 1H) 1 H NMR (300 MHz, CDCl 3): δ 8.45 (d, 1H), 8.33 (d, 1H), 8.18 (m, 4H), 7.84 ~ 7.65 (m, 6H), 7.50 ~ 7.06 (m, 24H) , 6.42 (t, 1 H)

MS/FAB: 828(M+)MS / FAB: 828 (M < + & gt ; ).

[[ 합성예Synthetic example 39] 화합물 [39]의 합성 39] Synthesis of compound [39]

1H NMR (300 MHz, CDCl3):δ 8.18(m, 4H), 7.84~7.65(m, 6H), 7.48~7.23(m, 17H), 7.09~7.06(m, 4H), 6.97(t, 1H), 6.77(t, 1H), 6.70(s, 1H), 6.01(s, 1H), 2.04(s, 3H), 1.94(s, 3H) 1 H NMR (300 MHz, CDCl 3 ):? 8.18 (m, 4H), 7.84-7.65 (m, 6H), 7.48-7.33 (m, 17H), 7.09-7. 1H), 6.77 (s, 3H), 6.94 (s, 1H)

MS/FAB: 832(M+)MS / FAB: 832 (M < + & gt ; ) [

[[ 합성예Synthetic example 40] 화합물 [40]의 합성 40] Synthesis of compound [40]

1H NMR (300 MHz, CDCl3):δ 8.18(m, 4H), 7.84~7.65(m, 6H), 7.48~7.06(m, 23H), 6.77(t, 1H), 6.70(s, 1H), 6.48(d, 1H), 6.31(t, 1H) 1 H NMR (300 MHz, CDCl 3): δ 8.18 (m, 4H), 7.84 ~ 7.65 (m, 6H), 7.48 ~ 7.06 (m, 23H), 6.77 (t, 1H), 6.70 (s, 1H) , 6.48 (d, 1 H), 6.31 (t, 1 H)

MS/FAB: 804(M+)MS / FAB: 804 (M < + & gt ; ).

[[ 합성예Synthetic example 41] 화합물 [41]의 합성 41] Synthesis of compound [41]

1H NMR (300 MHz, CDCl3):δ 8.45(d, 1H), 8.35(d, 1H), 8.18(d, 4H), 7.95~7.65(m, 7H), 7.50~7.06(m, 21H) 1 H NMR (300 MHz, CDCl 3): δ 8.45 (d, 1H), 8.35 (d, 1H), 8.18 (d, 4H), 7.95 ~ 7.65 (m, 7H), 7.50 ~ 7.06 (m, 21H)

MS/FAB: 818(M+)MS / FAB: 818 (M < + & gt ; ).

[[ 합성예Synthetic example 42] 화합물 [42]의 합성 42] Synthesis of compound [42]

1H NMR (300 MHz, CDCl3):δ 8.45(d, 1H), 8.35(d, 1H), 8.18(d, 4H), 7.98(d, 1H), 7.88~7.65(m, 7H), 7.42~7.07(m, 20H) 1 H NMR (300 MHz, CDCl 3): δ 8.45 (d, 1H), 8.35 (d, 1H), 8.18 (d, 4H), 7.98 (d, 1H), 7.88 ~ 7.65 (m, 7H), 7.42 ~ 7.07 (m, 20H)

MS/FAB: 818(M+)MS / FAB: 818 (M < + & gt ; ).

[[ 합성예Synthetic example 43] 화합물 [43]의 합성 43] Synthesis of compound [43]

1H NMR (300 MHz, CDCl3):δ 8.45(d, 1H), 8.35(d, 1H), 8.18(d, 4H), 7.88~7.65(m, 8H), 7.42~7.07(m, 20H) 1 H NMR (300 MHz, CDCl 3): δ 8.45 (d, 1H), 8.35 (d, 1H), 8.18 (d, 4H), 7.88 ~ 7.65 (m, 8H), 7.42 ~ 7.07 (m, 20H)

MS/FAB: 818(M+)MS / FAB: 818 (M < + & gt ; ).

[[ 합성예Synthetic example 44] 화합물 [44]의 합성 44] Synthesis of compound [44]

1H NMR (300 MHz, CDCl3):δ 8.45(d, 1H), 8.18(d, 5H), 7.84~7.65(m, 7H), 7.51~7.07(m, 21H), 0.56(s, 6H) 1 H NMR (300 MHz, CDCl 3): δ 8.45 (d, 1H), 8.18 (d, 5H), 7.84 ~ 7.65 (m, 7H), 7.51 ~ 7.07 (m, 21H), 0.56 (s, 6H)

MS/FAB: 845(M+)MS / FAB: 845 (M < + & gt ; ).

[[ 합성예Synthetic example 45] 화합물 [45]의 합성 45] Synthesis of compound [45]

1H NMR (300 MHz, CDCl3):δ 8.45(d, 1H), 8.18(d, 4H), 7.84~7.65(m, 8H), 7.42~7.07(m, 21H), 0.56(s, 6H) 1 H NMR (300 MHz, CDCl 3): δ 8.45 (d, 1H), 8.18 (d, 4H), 7.84 ~ 7.65 (m, 8H), 7.42 ~ 7.07 (m, 21H), 0.56 (s, 6H)

MS/FAB: 845(M+)MS / FAB: 845 (M < + & gt ; ).

[[ 합성예Synthetic example 46] 화합물 [46]의 합성 46] Synthesis of Compound [46]

1H NMR (300 MHz, CDCl3):δ 8.45(d, 1H), 8.18(d, 4H), 7.83~7.65(m, 7H), 7.56(d, 1H), 7.47~7.22(m, 21H), 1 H NMR (300 MHz, CDCl 3): δ 8.45 (d, 1H), 8.18 (d, 4H), 7.83 ~ 7.65 (m, 7H), 7.56 (d, 1H), 7.47 ~ 7.22 (m, 21H) ,

MS/FAB: 802.92(M+)MS / FAB: < / RTI & gt ; 802.92 (M + )

[[ 합성예Synthetic example 47] 화합물 [47]의 합성 47] Synthesis of compound [47]

1H NMR (300 MHz, CDCl3):δ 8.45(d, 1H), 8.18(d, 4H), 8.06(m, 2H), 7.95(d, 1H), 7.84~7.06(m, 28H) 1 H NMR (300 MHz, CDCl 3): δ 8.45 (d, 1H), 8.18 (d, 4H), 8.06 (m, 2H), 7.95 (d, 1H), 7.84 ~ 7.06 (m, 28H)

MS/FAB: 869.04(M+)MS / FAB: 869.04 (M < + & gt ; ).

[[ 합성예Synthetic example 48] 화합물 [48]의 합성 48] Synthesis of Compound [48]

1H NMR (300 MHz, CDCl3):δ 8.35(m, 1H), 8.18(d, 4H), 8.06(m, 2H), 7.95~7.88(m, 2H), 7.77~7.25(m, 22H), 7.09~6.97(m, 5H) 1 H NMR (300 MHz, CDCl 3): δ 8.35 (m, 1H), 8.18 (d, 4H), 8.06 (m, 2H), 7.95 ~ 7.88 (m, 2H), 7.77 ~ 7.25 (m, 22H) , 7.09 ~ 6.97 (m, 5H)

MS/FAB: 869.04(M+)MS / FAB: 869.04 (M < + & gt ; ).

[[ 합성예Synthetic example 49] 화합물 [49]의 합성 49] Synthesis of Compound [49]

1H NMR (300 MHz, CDCl3):δ 8.45~8.42(m, 4H), 8.18(d, 4H), 8.02(d, 1H), 7.94~7.77(m, 4H), 7.48~7.14(m, 28H) 1 H NMR (300 MHz, CDCl 3): δ 8.45 ~ 8.42 (m, 4H), 8.18 (d, 4H), 8.02 (d, 1H), 7.94 ~ 7.77 (m, 4H), 7.48 ~ 7.14 (m, 28H)

MS/FAB: 880.04(M+)MS / FAB: 880.04 (M < + & gt ; ).

[[ 합성예Synthetic example 50] 화합물 [50]의 합성 50] Synthesis of Compound [50]

1H NMR (300 MHz, CDCl3):δ 8.45(d, 2H), 8.18(d, 4H), 8.02~7.99(m, 2H), 7.84~7.77(m, 4H), 7.69(d, 1H), 7.48~7.14(m, 27H), 6.97(m, 1H) 1 H NMR (300 MHz, CDCl 3): δ 8.45 (d, 2H), 8.18 (d, 4H), 8.02 ~ 7.99 (m, 2H), 7.84 ~ 7.77 (m, 4H), 7.69 (d, 1H) , 7.48 ~ 7.14 (m, 27H), 6.97 (m, IH)

MS/FAB: 880.04(M+)MS / FAB: 880.04 (M < + & gt ; ).

[[ 합성예Synthetic example 51] 화합물 [51]의 합성 51] Synthesis of Compound [51]

1H NMR (300 MHz, CDCl3):δ 8.54~8.51(m, 3H), 8.28(m, 4H), 8.11(m, 1H), 7.93~7.86(m, 3H), 7.62~7.24(m, 30H) 1 H NMR (300 MHz, CDCl 3 ):? 8.54 to 8.51 (m, 3H), 8.28 (m, 4H), 8.11 30H)

MS/FAB: 880(M+)MS / FAB: 880 (M < + & gt ; ).

[[ 합성예Synthetic example 52] 화합물 [52]의 합성 52] Synthesis of compound [52]

1H NMR (300 MHz, CDCl3):δ 8.54~8.51(m, 3H), 8.28(m, 4H), 8.11(m, 1H), 7.93~7.86(m, 3H), 7.54(m, 1H), 7.62~7.24(m, 29H), 7.28(m, 1H) 1 H NMR (300 MHz, CDCl 3 ):? 8.54 to 8.51 (m, 3H), 8.28 (m, 4H), 8.11 , 7.62 ~ 7.24 (m, 29H), 7.28 (m, IH)

MS/FAB: 880(M+)MS / FAB: 880 (M < + & gt ; ).

[[ 합성예Synthetic example 53] 화합물 [53]의 합성 53] Synthesis of compound [53]

1H NMR (300 MHz, CDCl3):δ 8.54(m, 1H), 8.27(m, 4H), 8.11~8.08(m, 2H), 7.86~7.27(m, 3H), 7.24~7.57(m, 28H), 7.10~7.06(m, 2H) 1 H NMR (300 MHz, CDCl 3): δ 8.54 (m, 1H), 8.27 (m, 4H), 8.11 ~ 8.08 (m, 2H), 7.86 ~ 7.27 (m, 3H), 7.24 ~ 7.57 (m, 28H), 7.10 ~ 7.06 (m, 2H)

MS/FAB: 880(M+) MS / FAB: 880 (M < + & gt ; ).

[[ 합성예Synthetic example 54] 화합물 [54]의 합성 54] Synthesis of compound [54]

1H NMR (300 MHz, CDCl3):δ 8.54(m, 2H), 8.27(m, 4H), 8.11(m, 1H), 7.93~7.86(m, 4H), 7.57~7.10(m, 30H) 1 H NMR (300 MHz, CDCl 3 ):? 8.54 (m, 2H), 8.27 (m, 4H), 8.11

MS/FAB: 880(M+) MS / FAB: 880 (M < + & gt ; ).

[[ 합성예Synthetic example 55] 화합물 [55]의 합성 55] Synthesis of Compound [55]

1H NMR (300 MHz, CDCl3):δ 8.54(m, 1H), 8.27(m, 4H), 8.11(m, 1H), 7.93~7.86(m, 3H), 7.39~7.10(m, 32H) 1 H NMR (300 MHz, CDCl 3 ):? 8.54 (m, 1H), 8.27 (m, 4H), 8.11

MS/FAB: 880(M+)MS / FAB: 880 (M < + & gt ; ).

[[ 합성예Synthetic example 56] 화합물 [56]의 합성 56] Synthesis of compound [56]

1H NMR (300 MHz, CDCl3):δ 8.54~8.48(m, 2H), 8.27(m, 4H), 7.93~7.86(m, 3H), 7.62(m, 1H), 7.55~7.10(m, 25H), 6.90(m, 1H), 6.80~6.72(m, 3H), 6.62(m, 2H) 1 H NMR (300 MHz, CDCl 3): δ 8.54 ~ 8.48 (m, 2H), 8.27 (m, 4H), 7.93 ~ 7.86 (m, 3H), 7.62 (m, 1H), 7.55 ~ 7.10 (m, 2H), 6.90 (m, 1H), 6.80-6.72 (m, 3H), 6.62

MS/FAB: 908(M+)MS / FAB: 908 (M < + & gt ; ).

[[ 합성예Synthetic example 57] 화합물 [57]의 합성 57] Synthesis of compound [57]

1H NMR (300 MHz, CDCl3):δ 8.45(d, 2H), 8.20(d, 2H), 8.10~7.97(m, 5H), 7.86~7.77(m, 4H), 7.65(d, 2H), 7.48~7.06(m, 26H) 1 H NMR (300 MHz, CDCl 3): δ 8.45 (d, 2H), 8.20 (d, 2H), 8.10 ~ 7.97 (m, 5H), 7.86 ~ 7.77 (m, 4H), 7.65 (d, 2H) , 7.48 ~ 7.06 (m, 26H)

MS/FAB: 876(M+)MS / FAB: 876 (M < + & gt ; ).

[[ 합성예Synthetic example 58] 화합물 [58]의 합성 58] Synthesis of Compound [58]

1H NMR (300 MHz, CDCl3):δ 8.45(d, 2H), 8.20(d, 4H), 8.10(s, 2H), 8.02(d, 1H), 7.84~7.77(m, 4H), 7.65(d, 2H), 7.53~7.35(m, 14H), 7.25~7.07(m, 12H) 1 H NMR (300 MHz, CDCl 3): δ 8.45 (d, 2H), 8.20 (d, 4H), 8.10 (s, 2H), 8.02 (d, 1H), 7.84 ~ 7.77 (m, 4H), 7.65 (d, 2H), 7.53 ~ 7.35 (m, 14H), 7.25 ~ 7.07 (m, 12H)

MS/FAB: 876(M+)MS / FAB: 876 (M < + & gt ; ).

[[ 합성예Synthetic example 59] 화합물 [59]의 합성 59] Synthesis of Compound [59]

1H NMR (300 MHz, CDCl3):δ 8.45(d, 2H), 8.13(s, 1H), 8.02(d, 1H), 7.84~7.69(m, 10H), 7.48~7.06(m, 26H) 1 H NMR (300 MHz, CDCl 3 ):? 8.45 (d, 2H), 8.13 (s, IH), 8.02 (d, IH), 7.84-7.69

MS/FAB: 877(M+)MS / FAB: 877 (M < + & gt ; ).

[[ 합성예Synthetic example 60] 화합물 [60]의 합성 60] Synthesis of Compound [60]

1H NMR (300 MHz, CDCl3):δ 8.45(d, 1H), 8.20(m, 2H), 8.10~8.02(m, 5H), 7.86~7.77(m, 3H), 7.65(d, 2H), 7.53~7.06(m, 28H) 1 H NMR (300 MHz, CDCl 3): δ 8.45 (d, 1H), 8.20 (m, 2H), 8.10 ~ 8.02 (m, 5H), 7.86 ~ 7.77 (m, 3H), 7.65 (d, 2H) , 7.53 ~ 7.06 (m, 28H)

MS/FAB: 876(M+)MS / FAB: 876 (M < + & gt ; ).

[[ 합성예Synthetic example 61] 화합물 [61]의 합성 61] Synthesis of Compound [61]

1H NMR (300 MHz, CDCl3):δ 8.45(d, 1H), 8.20(m, 4H), 8.10~8.02(m, 3H), 7.86~7.77(m, 3H), 7.65(d, 2H), 7.53~7.06(m, 28H) 1 H NMR (300 MHz, CDCl 3): δ 8.45 (d, 1H), 8.20 (m, 4H), 8.10 ~ 8.02 (m, 3H), 7.86 ~ 7.77 (m, 3H), 7.65 (d, 2H) , 7.53 ~ 7.06 (m, 28H)

MS/FAB: 876(M+)MS / FAB: 876 (M < + & gt ; ).

[[ 합성예Synthetic example 62] 화합물 [62]의 합성 62] Synthesis of Compound [62]

1H NMR (300 MHz, CDCl3):δ 8.45(d, 1H), 8.13(s, 1H), 8.02(d, 1H), 7.83~7.65(m, 9H), 7.53~7.06(m, 28H) 1 H NMR (300 MHz, CDCl 3): δ 8.45 (d, 1H), 8.13 (s, 1H), 8.02 (d, 1H), 7.83 ~ 7.65 (m, 9H), 7.53 ~ 7.06 (m, 28H)

MS/FAB: 877(M+)MS / FAB: 877 (M < + & gt ; ).

[[ 합성예Synthetic example 63] 화합물 [63]의 합성 63] Synthesis of Compound [63]

1H NMR (300 MHz, CDCl3):δ 8.54(m, 1H), 8.44(m, 1H), 8.29(m, 2H), 8.19~8.06(m, 5H), 7.97~7.86(m, 4H), 7.79~7.74(m, 3H), 7.53~7.18(m, 20H) 1 H NMR (300 MHz, CDCl 3): δ 8.54 (m, 1H), 8.44 (m, 1H), 8.29 (m, 2H), 8.19 ~ 8.06 (m, 5H), 7.97 ~ 7.86 (m, 4H) , 7.79 ~ 7.74 (m, 3H), 7.53 ~ 7.18 (m, 20H)

MS/FAB: 817(M+)MS / FAB: 817 (M < + & gt ; ).

[[ 합성예Synthetic example 64] 화합물 [64]의 합성 64] Synthesis of compound [64]

1H NMR (300 MHz, CDCl3):δ 8.54(m, 1H), 8.44(m, 1H), 8.29(m, 4H), 8.19(s, 2H), 8.07(m, 1H), 7.97~7.74(m, 7H), 7.53~7.46(m, 10H), 7.34~7.18(m, 10H) 1 H NMR (300 MHz, CDCl 3 ):? 8.54 (m, IH), 8.44 (m, IH), 8.29 (m, 7H), 7.53-7.46 (m, 10H), 7.34-7.18 (m, 10H)

MS/FAB: 817(M+)MS / FAB: 817 (M < + & gt ; ).

[[ 합성예Synthetic example 65] 화합물 [65]의 합성 65] Synthesis of compound [65]

1H NMR (300 MHz, CDCl3):δ 8.54(m, 1H), 8.44(m, 1H), 8.22(s, 1H), 8.07(m, 1H), 7.97~7.50(m, 11H), 7.62(m, 1H), 7.55~7.18(m, 19H) 1 H NMR (300 MHz, CDCl 3 ):? 8.54 (m, IH), 8.44 (m, IH), 8.22 (m, 1 H), 7.55-7.18 (m, 19 H)

MS/FAB: 817(M+)MS / FAB: 817 (M < + & gt ; ).

[[ 합성예Synthetic example 66] 화합물 [66]의 합성 66] Synthesis of compound [66]

1H NMR (300 MHz, CDCl3):δ 8.54(d, 1H), 8.44(d, 1H), 8.29(d, 2H), 8.19~8.06(m, 4H), 7.97~7.85(m, 5H), 7.77~7.74(m, 3H), 7.53~7.15(m, 20H) 1 H NMR (300 MHz, CDCl 3): δ 8.54 (d, 1H), 8.44 (d, 1H), 8.29 (d, 2H), 8.19 ~ 8.06 (m, 4H), 7.97 ~ 7.85 (m, 5H) , 7.77 ~ 7.74 (m, 3H), 7.53 ~ 7.15 (m, 20H)

MS/FAB: 817(M+)MS / FAB: 817 (M < + & gt ; ).

[[ 합성예Synthetic example 67] 화합물 [67]의 합성 67] Synthesis of compound [67]

1H NMR (300 MHz, CDCl3):δ 8.54(m, 1H), 8.44(m, 1H), 8.29(m, 4H), 8.19(s, 2H), 7.97~7.85(m, 5H), 7.77~7.74(m, 3H), 7.62~7.46(m, 10H), 7.34~7.15(m, 10H) 1 H NMR (300 MHz, CDCl 3): δ 8.54 (m, 1H), 8.44 (m, 1H), 8.29 (m, 4H), 8.19 (s, 2H), 7.97 ~ 7.85 (m, 5H), 7.77 (M, 3H), 7.62-7.46 (m, 10H), 7.34-7.15 (m, 10H)

MS/FAB: 817(M+)MS / FAB: 817 (M < + & gt ; ).

[[ 합성예Synthetic example 68] 화합물 [68]의 합성 68] Synthesis of compound [68]

1H NMR (300 MHz, CDCl3):δ 8.54(m, 1H), 8.44(m, 1H), 8.22(s, 1H), 7.97~7.74(m, 12H), 7.62(m, 1H), 7.55~7.15(m, 19H) 1 H NMR (300 MHz, CDCl 3 ):? 8.54 (m, IH), 8.44 (m, IH), 8.22 (s, IH), 7.97-7.74 ~ 7.15 (m, 19H)

MS/FAB: 817(M+)MS / FAB: 817 (M < + & gt ; ).

[[ 합성예Synthetic example 69] 화합물 [69]의 합성 69] Synthesis of compound [69]

1H NMR (300 MHz, CDCl3):δ 8.45(d, 2H), 8.20(m, 2H), 8.10(s, 2H), 8.02~7.98(m, 2H), 7.84~7.74(m, 6H), 7.65(d, 1H), 7.47~7.31(m, 14H), 7.25~7.06(m, 11H), 6.97(t, 1H) 1 H NMR (300 MHz, CDCl 3): δ 8.45 (d, 2H), 8.20 (m, 2H), 8.10 (s, 2H), 8.02 ~ 7.98 (m, 2H), 7.84 ~ 7.74 (m, 6H) , 7.65 (d, IH), 7.47-7.31 (m, 14H), 7.25-7.06 (m,

MS/FAB: 876(M+)MS / FAB: 876 (M < + & gt ; ).

[[ 합성예Synthetic example 70] 화합물 [70]의 합성 70] Synthesis of compound [70]

1H NMR (300 MHz, CDCl3):δ 8.45(d, 1H), 8.13(s, 1H), 8.02(d, 1H) 7.84~7.65(m, 9H), 7.53~7.30(m, 17H), 7.25~7.06(m, 10H), 6.97(t, 1H) 1 H NMR (300 MHz, CDCl 3): δ 8.45 (d, 1H), 8.13 (s, 1H), 8.02 (d, 1H) 7.84 ~ 7.65 (m, 9H), 7.53 ~ 7.30 (m, 17H), 7.25 - 7.06 (m, 10 H), 6.97 (t, 1 H)

MS/FAB: 877(M+)MS / FAB: 877 (M < + & gt ; ).

[[ 합성예Synthetic example 71] 화합물 [71]의 합성 71] Synthesis of compound [71]

1H NMR (300 MHz, CDCl3):δ 8.45(d, 1H), 8.20(m, 4H), 8.10(s, 2H), 8.02(d, 1H) 7.84(d, 1H), 7.77(d, 2H), 7.53~7.28(m, 19H), 7.23~7.13(m, 13H) 1 H NMR (300 MHz, CDCl 3): δ 8.45 (d, 1H), 8.20 (m, 4H), 8.10 (s, 2H), 8.02 (d, 1H) 7.84 (d, 1H), 7.77 (d, 2H), 7.53-7.28 (m, 19H), 7.23-7.13 (m, 13H)

MS/FAB: 878(M+)MS / FAB: 878 (M < + & gt ; ).

[[ 합성예Synthetic example 72] 화합물 [72]의 합성 72] Synthesis of compound [72]

1H NMR (300 MHz, CDCl3):δ 8.55(d, 2H), 8.30(m, 2H), 8.20~8.07(m, 5H), 7.94~7.87(m, 4H), 7.57~7.11(m, 30H) 1 H NMR (300 MHz, CDCl 3): δ 8.55 (d, 2H), 8.30 (m, 2H), 8.20 ~ 8.07 (m, 5H), 7.94 ~ 7.87 (m, 4H), 7.57 ~ 7.11 (m, 30H)

MS/FAB: 878(M+)MS / FAB: 878 (M < + & gt ; ).

[[ 합성예Synthetic example 73] 화합물 [73]의 합성 73] Synthesis of compound [73]

1H NMR (300 MHz, CDCl3):δ 8.55(d, 1H), 8.23(s, 1H), 8.12(d, 1H), 7.94~7.79(m, 7H), 7.63~7.11(m, 32H) 1 H NMR (300 MHz, CDCl 3): δ 8.55 (d, 1H), 8.23 (s, 1H), 8.12 (d, 1H), 7.94 ~ 7.79 (m, 7H), 7.63 ~ 7.11 (m, 32H)

MS/FAB: 879(M+)MS / FAB: 879 (M < + & gt ; ).

[[ 합성예Synthetic example 74] 화합물 [74]의 합성 74] Synthesis of compound [74]

1H NMR (300 MHz, CDCl3):δ 8.55(d, 1H), 8.49(s, 1H), 8.23(s, 1H), 7.94~7.79(m, 7H), 7.63(d, 1H), 7.53~7.11(m, 25H), 6.91(t, 1H), 6.81~6.73(m, 3H), 6.63(d, 2H) 1 H NMR (300 MHz, CDCl 3): δ 8.55 (d, 1H), 8.49 (s, 1H), 8.23 (s, 1H), 7.94 ~ 7.79 (m, 7H), 7.63 (d, 1H), 7.53 (M, 2H), 6.91 (t, 1H), 6.81-6.73 (m, 3H)

MS/FAB: 907(M+)MS / FAB: < / RTI & gt ; 907 (M + )

이하에서, 실시예를 통하여 본 발명을 보다 상세히 설명한다. 그러나, 하기의 실시예는 본 발명을 더욱 구체적으로 설명하기 위한 것으로서, 본 발명의 범위가 하기의 실시예에 의하여 한정되는 것은 아니다. 하기의 실시예는 본 발명의 범위 내에서 당업자에 의해 적절히 수정, 변경될 수 있다. Hereinafter, the present invention will be described in more detail by way of examples. However, the following examples are intended to further illustrate the present invention, and the scope of the present invention is not limited by the following examples. The following examples can be appropriately modified and changed by those skilled in the art within the scope of the present invention.

비교예Comparative Example 1. One.

하기 화학식 a로 표시되는 화합물을 인광 녹색 호스트로 사용하고, 하기 화학식 c로 표시되는 화합물을 인광 녹색 도판트로 사용하고, 2-TNATA(4,4',4"-tris(N-naphthalen-2-yl)-N-phenylamino)-triphenylamine)을 정공주입층 물질로 사용하고, α-NPD(N,N'-di(naphthalene-1-yl)-N,N'-diphenylbenzidine)을 정공수송층 물질로 사용하여, 다음과 같은 구조를 갖는 유기발광소자를 제작하였다:ITO/2-TNATA(80 nm)/α-NPD(30 nm)/화합물a+화합물c(30 nm)/Alq3(30nm)/LiF(0.5nm)/Al(60nm).Wherein the compound represented by the following formula (a) is used as a phosphorescent green host and the compound represented by the following formula (c) is used as a phosphorescent green dopant, and 2-TNATA (4,4 ' (N, N'-di (naphthylene-1-yl) -N, N'-diphenylbenzidine) was used as a hole transport layer material (30 nm) / Alq 3 (30 nm) / LiF (30 nm) / compound (30 nm) / compound a + compound 30 nm / ITO / 2-TNATA 0.5 nm) / Al (60 nm).

애노드는 코닝(Corning)사의 15Ω/cm2(1000Å) ITO 유리기판을 50mm x 50mm x 0.7mm 크기로 잘라서 아세톤, 이소프로필알콜과 순수한 물속에서 각 15분 동안 초음파 세정을 한 후, 30분동안 UV 오존세정을 하여 사용하였다. 상기 기판 상부에 2-TNATA를 진공증착하여 80 nm 두께의 공주입층을 형성하였다. 상기 정공주입층 상부에, α-NPD를 진공 증착하여 30 nm 두께의 정공수송층을 형성하였다. 상기 정공수송층 상부에 화학식 a로 표시되는 화합물 및 화학식 c로 표시되는 화합물(도핑률:10%)를 진공 증착하여 30 nm두께의 발광층을 형성하였다. 이후, 상기 발광층 상부에 Alq3화합물을 30 nm의두께로 진공증착하여 전자수송층을 형성하였다. 상기 전자수송층 상부에 LiF0.5 nm(전자주입층)과 Al 60 nm(캐소드)를 순차적으로 진공증착하여, 표 3에 표시된 바와 같은 유기발광소자를 제조하였다. 이를 비교샘플 1이라고 한다.An anode was prepared by cutting Corning's 15 Ω / cm 2 (1000 Å) ITO glass substrate into 50 mm × 50 mm × 0.7 mm size, ultrasonically cleaning it in acetone, isopropyl alcohol and pure water for 15 minutes each, Ozone was cleaned and used. 2-TNATA was vacuum deposited on the substrate to form a 80 nm thick princess grain layer. On top of the hole injection layer, α-NPD was vacuum deposited to form a hole transport layer having a thickness of 30 nm. A compound represented by Formula (a) and a compound represented by Formula (c) (doping ratio: 10%) were vacuum deposited on the hole transport layer to form a light emitting layer with a thickness of 30 nm. Then, an Alq 3 compound was vacuum deposited on the light emitting layer to a thickness of 30 nm to form an electron transporting layer. LiF 0.5 nm (electron injecting layer) and Al 60 nm (cathode) were sequentially vacuum-deposited on the electron transporting layer to form an organic light emitting device as shown in Table 3. [ This is referred to as Comparative Sample 1.

비교예2Comparative Example 2 ..

하기 화학식 b로 표시되는 화합물을 인광 녹색 호스트로 사용하고, 하기 화학식 c로 표시되는 화합물을 인광 녹색 도판트로 사용하고, 2-TNATA(4,4',4"-tris(N-naphthalen-2-yl)-N-phenylamino)-triphenylamine)을 정공주입층 물질로 사용하고, α-NPD(N,N'-di(naphthalene-1-yl)-N,N'-diphenylbenzidine)을 정공수송층 물질로 사용하여, 다음과 같은 구조를 갖는 유기발광소자를 제작하였다:ITO/2-TNATA(80 nm)/α-NPD(30 nm)/화합물b+화합물c(30 nm)/Alq3(30nm)/LiF(0.5nm)/Al(60nm).Wherein the compound represented by the following formula (b) is used as a phosphorescent green host and the compound represented by the following formula (c) is used as a phosphorescent green dopant, and 2-TNATA (4,4 ' (N, N'-di (naphthylene-1-yl) -N, N'-diphenylbenzidine) was used as a hole transport layer material (30 nm) / Alq 3 (30 nm) / LiF (30 nm) / compound (30 nm) / compound (30 nm) / ITO / 2-TNATA 0.5 nm) / Al (60 nm).

애노드는 코닝(Corning)사의 15Ω/cm2(1000Å) ITO 유리기판을 50mm x 50mm x 0.7mm 크기로 잘라서 아세톤, 이소프로필알콜과 순수한 물속에서 각 15분 동안 초음파 세정을 한 후, 30분 동안 UV 오존세정을 하여 사용하였다. 상기 기판 상부에 2-TNATA를 진공 증착하여 80 nm 두께의 정공주입층을 형성하였다. 상기 정공주입층 상부에, α-NPD를 진공 증착하여 30nm 두께의 정공수송층을 형성하였다. 상기 정공수송층 상부에 화학식 a로 표시되는 화합물 및 화학식 c로 표시되는 화합물(도핑율:10%)을 진공 증착하여 30nm 두께의 발광층을 형성하였다. 이후, 상기 발광층 상부에 Alq3화합물을 30nm의 두께로 진공증착하여 전자수송층을 형성하였다. 상기 전자수송층 상부에 LiF0.5nm(전자주입층)과 Al 60nm(캐소드)를 순차적으로 진공증착하여, 표 2에 표시된 바와 같은 유기발광소자를 제조하였다. 이를 비교샘플 2라고 한다.An anode was prepared by cutting Corning's 15 Ω / cm 2 (1000 Å) ITO glass substrate into 50 mm × 50 mm × 0.7 mm size, ultrasonically cleaning it in acetone, isopropyl alcohol and pure water for 15 minutes each, Ozone was cleaned and used. 2-TNATA was vacuum deposited on the substrate to form a hole injection layer having a thickness of 80 nm. On top of the hole injection layer,? -NPD was vacuum deposited to form a hole transport layer having a thickness of 30 nm. A compound represented by Formula (a) and a compound represented by Formula (c) (doping ratio: 10%) were vacuum-deposited on the hole transport layer to form a 30 nm thick light emitting layer. Then, an Alq 3 compound was vacuum deposited on the light emitting layer to a thickness of 30 nm to form an electron transporting layer. LiF 0.5 nm (electron injecting layer) and Al 60 nm (cathode) were sequentially vacuum-deposited on the electron transporting layer to produce an organic light emitting device as shown in Table 2. This is referred to as Comparative Sample 2.

Figure 112015052111785-pat00096
Figure 112015052111785-pat00096

실시예1Example 1 ~73.~ 73.

상기 비교예 1 중에서, 발광층 인광 호스트 화합물 a 대신 상기 합성예에 개시된 화학식 1-6 및 8-74로 표시되는 화합물들을 인광 녹색 호스트 화합물로 각각 이용한 것을 제외하고는 상기 비교예 1과 동일한 방법으로 ITO/2-TNATA(80 nm)/α-NPD(30 nm)/[인광 녹색 호스트 화합물 1-6 및 8-74 중 하나+화합물c(10%)](30 nm)/Alq3(30nm)/LiF(0.5nm)/Al(60nm)의 구조를 갖는 유기발광소자를 제조하였다. 이를 각각 샘플 1-6 및 8-74라고 한다.In the same manner as in Comparative Example 1 except that the phosphorescent host compound a in the above-mentioned synthesis example was used as a phosphorescent green host compound in the above Comparative Example 1, ITO (30 nm) / Alq 3 (30 nm) / 2-TNATA (80 nm) /? -NPD (30 nm) / [phosphorescent green host compound 1-6 and one of 8-74 + compound c An organic light emitting device having a structure of LiF (0.5 nm) / Al (60 nm) was manufactured. These are referred to as Samples 1-6 and 8-74, respectively.

평가예1Evaluation example 1 : : 비교샘플1Comparative Sample 1 , 2 및 샘플 1-6 및 8-74의 발광 특성평가, 2 and samples 1-6 and 8-74

비교샘플 1, 2 및 샘플 1-6 및 8-74에 대하여, Keithleysourcemeter"2400", KONIKA MINOLTA "CS-2000"을 이용하여 발광휘도, 발광효율, 발광피크를 각각 평가하여, 그 결과를 하기 [제2표군(群)]에 나타내었다. 상기 샘플들은 511~517nm 범위에서 녹색 발광피크값을 보여주었다.The luminescence brightness, the luminescence efficiency and the luminescence peak were evaluated using Keithleysourcemeter "2400" and KONIKA MINOLTA "CS-2000" for Comparative Samples 1 and 2 and Samples 1-6 and 8-74, Second group (group)]. The samples showed green emission peak values in the 511 to 517 nm range.

[제2표군(群)][Second group (group)]

Figure 112015052111785-pat00097
Figure 112015052111785-pat00098
Figure 112015052111785-pat00099
Figure 112015052111785-pat00097
Figure 112015052111785-pat00098
Figure 112015052111785-pat00099

상기 [제2표군(群)]부터 확인되는 바와 같이 샘플 1-6 및 8-74는 비교샘플 1, 2에 비하여 향상된 발광 특성을 나타내었다.Samples 1-6 and 8-74 exhibited improved luminescence properties as compared to Comparative Samples 1 and 2, as confirmed from [second set of group (s)].

평가예Evaluation example 2: 비교샘플 1, 2 및 샘플 1-6 및 8-74의 수명 특성 평가 2: Evaluation of life characteristics of Comparative Samples 1 and 2 and Samples 1-6 and 8-74

비교샘플 1, 2 및 샘플 1-6 및 8-74에 대하여, ENC technology사의 LTS-1004AC 수명측정장치를 이용하여 3000 nit를 기준으로 수명이 97%에 도달하는 시간을 각각측정하여, 그 결과를 하기 [제3표군(群)]에 나타내었다.For Comparative Samples 1 and 2 and Samples 1-6 and 8-74, the time to reach 97% of life on the basis of 3000 nits was measured using an LVS-1004AC life measuring device manufactured by ENC technology, Is shown in the following [third group (group)].

[제3표군(群)][Group 3]

Figure 112015052111785-pat00100
Figure 112015052111785-pat00101
Figure 112015052111785-pat00102
Figure 112015052111785-pat00103
Figure 112015052111785-pat00100
Figure 112015052111785-pat00101
Figure 112015052111785-pat00102
Figure 112015052111785-pat00103

상기 [제3표군(群)]로부터 확인되는 바와 같이 샘플 1-6 및 8-74는 비교샘플 1, 2에 비하여 향상된 수명 특성을 나타내었다. Samples 1-6 and 8-74 exhibited improved lifespan characteristics as compared to Comparative Samples 1 and 2, as confirmed from [third set of group (s)].

Claims (8)

하기 화합물 49 또는 51로 표시되는 유기발광화합물.
Figure 112015096423778-pat00166
An organic light-emitting compound represented by the following compound 49 or 51.
Figure 112015096423778-pat00166
삭제delete 삭제delete 삭제delete 제 1 항에 있어서,
상기 유기발광화합물은 유기전기발광소자용 재료 중 인광 녹색 호스트 물질인 것을 특징으로 하는 유기발광화합물.
The method according to claim 1,
Wherein the organic light emitting compound is a phosphorescent green host material in a material for an organic electroluminescence device.
음극과 양극 사이에 적어도 발광층을 포함하는 일층 또는 복수층으로 이루어지는 유기 박막층이 협지되어 있는 유기전기발광소자에 있어서,
상기 유기 박막층 중 적어도 1층 이상이 청구항 1의 유기발광화합물을 1종 단독으로 또는 2종의 조합으로 함유하는 것을 특징으로 하는 유기전기발광소자.
An organic electroluminescent device in which an organic thin film layer composed of one layer or a plurality of layers including at least a light emitting layer is sandwiched between a cathode and an anode,
Wherein at least one of the organic thin film layers contains the organic electroluminescent compound of claim 1 singly or in combination.
제 6 항에 있어서,
상기 유기발광화합물이 인광 녹색 호스트 물질로 함유되는 것을 특징으로 하는 유기전기발광소자.
The method according to claim 6,
Wherein the organic electroluminescent compound is contained as a phosphorescent green host material.
제 6 항 또는 7 항에 있어서,
상기 유기전기발광소자가
양극, 정공주입층, 정공수송층, 발광층, 전자수송층, 전자주입층 및 음극이 이 순서대로 적층된 구조를 갖는 것을 특징으로 하는 유기전기발광소자.
7. The method according to claim 6 or 7,
The organic electroluminescent device
Wherein the anode, the hole injecting layer, the hole transporting layer, the light emitting layer, the electron transporting layer, the electron injecting layer, and the cathode are stacked in this order.
KR1020150076325A 2012-07-05 2015-05-29 New organic electroluminescent compounds and organic electroluminescent device comprising the same KR101600434B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020120073487 2012-07-05
KR20120073487 2012-07-05

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020130065493A Division KR101540053B1 (en) 2012-07-05 2013-06-07 New organic electroluminescent compounds and organic electroluminescent device comprising the same

Publications (2)

Publication Number Publication Date
KR20150066509A KR20150066509A (en) 2015-06-16
KR101600434B1 true KR101600434B1 (en) 2016-03-09

Family

ID=50142631

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020130065493A KR101540053B1 (en) 2012-07-05 2013-06-07 New organic electroluminescent compounds and organic electroluminescent device comprising the same
KR1020150076325A KR101600434B1 (en) 2012-07-05 2015-05-29 New organic electroluminescent compounds and organic electroluminescent device comprising the same

Family Applications Before (1)

Application Number Title Priority Date Filing Date
KR1020130065493A KR101540053B1 (en) 2012-07-05 2013-06-07 New organic electroluminescent compounds and organic electroluminescent device comprising the same

Country Status (1)

Country Link
KR (2) KR101540053B1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170186967A1 (en) * 2014-06-11 2017-06-29 Hodogaya Chemical Co., Ltd. Pyrimidine derivative and an organic electroluminescent device
US11495749B2 (en) 2015-04-06 2022-11-08 Universal Display Corporation Organic electroluminescent materials and devices
US10693082B2 (en) * 2015-04-06 2020-06-23 Universal Display Corporation Organic electroluminescent materials and devices
US11818949B2 (en) 2015-04-06 2023-11-14 Universal Display Corporation Organic electroluminescent materials and devices
US10177318B2 (en) 2015-10-29 2019-01-08 Universal Display Corporation Organic electroluminescent materials and devices
JP6859587B2 (en) * 2016-03-28 2021-04-14 エルジー・ケム・リミテッド Compounds and organic electronic devices containing them
KR20170129599A (en) * 2016-05-17 2017-11-27 롬엔드하스전자재료코리아유한회사 Organic electroluminescent compound, organic electroluminescent material and organic electroluminescent device comprising the same
WO2017200210A1 (en) * 2016-05-17 2017-11-23 Rohm And Haas Electronic Materials Korea Ltd. Organic electroluminescent compound, organic electroluminescent material and organic electroluminescent device comprising the same
KR102080286B1 (en) 2017-05-22 2020-04-07 주식회사 엘지화학 Novel compound and organic light emitting device comprising the same
KR102070941B1 (en) * 2017-06-21 2020-01-29 주식회사 엘지화학 Novel hetero-cyclic compound and organic light emitting device comprising the same
KR102078463B1 (en) * 2017-07-28 2020-02-17 주식회사 엘지화학 Fluorene derivative and organic light emitting device comprising the same
KR102139859B1 (en) 2017-08-02 2020-07-30 주식회사 엘지화학 Hetero-cyclic compound and organic light emitting device comprising the same
EP3483154A1 (en) * 2017-11-09 2019-05-15 Novaled GmbH Compounds comprising triazine, fluorene and aryl groups and their use in organic electronic devices
US11834459B2 (en) 2018-12-12 2023-12-05 Universal Display Corporation Host materials for electroluminescent devices
KR102624686B1 (en) * 2019-07-05 2024-01-11 주식회사 엘지화학 Novel compound and organic light emitting device comrising the same
US20230099759A1 (en) * 2019-12-23 2023-03-30 Idemitsu Kosan Co.,Ltd. Polycyclic compound, material for an organic electroluminescence device and an organic electroluminescence device comprising the polycyclic compound
KR20210106645A (en) * 2020-02-21 2021-08-31 주식회사 엘지화학 Heterocyclic compound and organic light emitting device comprising same
CN114380803A (en) * 2020-10-16 2022-04-22 常州强力昱镭光电材料有限公司 Spirobifluorene compound, electron transport composition and organic electroluminescent device
CN114105992B (en) * 2021-06-18 2023-11-14 陕西莱特迈思光电材料有限公司 Nitrogen-containing compound, organic electroluminescent device and electronic device comprising same
CN114702508A (en) * 2022-02-23 2022-07-05 京东方科技集团股份有限公司 Triazine derivative, light-emitting device and display device

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011071474A (en) 2009-07-31 2011-04-07 Fujifilm Corp Charge transport material and organic electroluminescent element
WO2011060877A2 (en) 2009-11-17 2011-05-26 Merck Patent Gmbh Materials for organic light emitting devices
CN102838443A (en) 2012-09-19 2012-12-26 武汉大学 Hexafluorenylbenzene derivative and application thereof to organic photoelectric functional material

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10356099A1 (en) * 2003-11-27 2005-07-07 Covion Organic Semiconductors Gmbh Organic electroluminescent element
DE102008064200A1 (en) * 2008-12-22 2010-07-01 Merck Patent Gmbh Organic electroluminescent device
EP2431445B1 (en) * 2009-05-15 2016-11-23 Cheil Industries Inc. Compound for organic photoelectric device and organic photoelectric device comprising same
DE102010013068A1 (en) * 2010-03-26 2011-09-29 Merck Patent Gmbh Connections for electronic devices

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011071474A (en) 2009-07-31 2011-04-07 Fujifilm Corp Charge transport material and organic electroluminescent element
WO2011060877A2 (en) 2009-11-17 2011-05-26 Merck Patent Gmbh Materials for organic light emitting devices
CN102838443A (en) 2012-09-19 2012-12-26 武汉大学 Hexafluorenylbenzene derivative and application thereof to organic photoelectric functional material

Also Published As

Publication number Publication date
KR101540053B1 (en) 2015-07-29
KR20150066509A (en) 2015-06-16
KR20140009019A (en) 2014-01-22

Similar Documents

Publication Publication Date Title
KR101600434B1 (en) New organic electroluminescent compounds and organic electroluminescent device comprising the same
KR101600453B1 (en) New organic electroluminescent compounds and organic electroluminescent device comprising the same
KR101529164B1 (en) New organic electroluminescent compounds and organic electroluminescent device comprising the same
KR101540058B1 (en) New organic electroluminescent compounds and organic electroluminescent device comprising the same
KR102160946B1 (en) Organic electroluminescent compound comprising acridine derivative and organic electroluminescent device comprising same
KR101663527B1 (en) New organic electroluminescent compounds and organic electroluminescent device comprising the same
KR101692253B1 (en) Novel organic electroluminescent compound, organic electroluminescent device including the same and electric apparatus
KR101532299B1 (en) New electron transporting compounds and organic electroluminescent device comprising the same
KR20090028943A (en) Hole injection/transporting layer material and organic electroluminescent device comprising same
KR101512014B1 (en) New arylcarbazolylacridine-based organic electroluminescent compounds and organic electroluminescent device comprising the same
KR20140027030A (en) Organic light compound and organic light device using the same
KR101551466B1 (en) New organic electroluminescent compounds and organic electroluminescent device comprising the same
KR101536169B1 (en) New organic electroluminescent compounds and organic electroluminescent device comprising the same
KR102387855B1 (en) Novel electroluminescent compound and organic electroluminescent device comprising same
KR20170075645A (en) New organic compounds and organic electroluminescent device comprising the same
KR101536163B1 (en) New organic electroluminescent compounds and organic electroluminescent device comprising the same
KR102394380B1 (en) Novel electroluminescent compound and organic electroluminescent device comprising same
KR101565039B1 (en) Novel organic compounds and an organic electroluminescent device comprising the same
KR101548359B1 (en) New organic electroluminescent compounds and organic electroluminescent device comprising the same
KR20140027018A (en) New organic electroluminescent compounds and organic electroluminescent device comprising the same
KR102630325B1 (en) Novel compound and organic electroluminescent device comprising the same
KR101512023B1 (en) New organic electroluminescent compounds and organic electroluminescent device comprising the same
KR20090016048A (en) Fluorescent green/blue-emitting material and organic electroluminescent device comprising same
KR100951441B1 (en) Hole injection/transporting layer material and organic electroluminescent device comprising same
KR101636968B1 (en) New electron injection layer compounds and organic electroluminescent device comprising the same

Legal Events

Date Code Title Description
A107 Divisional application of patent
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
FPAY Annual fee payment

Payment date: 20190214

Year of fee payment: 4

FPAY Annual fee payment

Payment date: 20200204

Year of fee payment: 5